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Abstract 
A RANDOMIZED TRIAL OF CBT4CBT FOR WOMEN IN RESIDENTIAL TREATMENT 
FOR SUBSTANCE USE DISORDERS 
 
by Sydney S. Kelpin, M.S. 
 
A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor of 
Philosophy at Virginia Commonwealth University 
 
Virginia Commonwealth University, 2020 
 
Director: Dace S. Svikis, Ph.D., Professor, Department of Psychology 
 
 
 
Women with substance use disorders (SUD) face unique barriers to substance use 
treatment, and as a result, are less likely than their male counterparts to seek treatment for the 
disorder. Cognitive behavioral therapy (CBT) is an evidence-based treatment known to reduce 
relapse rates by teaching clients to recognize and respond to their cues for substance use. Recent 
research suggests CBT may be particularly of benefit to women. Despite the effectiveness of 
CBT, its dissemination in clinical practice is limited due to a range of barriers (e.g., time, cost). 
Computer-based training for cognitive behavioral therapy (CBT4CBT) offers an opportunity to 
improve the quality and reach of SUD treatment services that is both feasible and cost-effective. 
Research to date has supported the effectiveness of CBT4CBT in outpatient settings; however, it 
has not yet been tested in residential treatment. The present study was a two-arm clinical trial 
comparing women randomized to either standard residential treatment plus access to the 
CBT4CBT program (N = 34) or residential treatment alone (TAU; N = 29). Assessments 
occurred at baseline, discharge from residential care, and at 4 and 12-weeks post-discharge. 
Although the present study was not powered for statistical significance, findings were in the 
predicted direction, with women in the CBT4CBT group reporting lower likelihood of relapse, 
     
 ix 
longer time to relapse, and fewer days of substance use in the follow-up period compared to 
TAU. This pattern was most evident for women not receiving pharmacological treatment for 
opioid use disorder. Exploratory analyses examined correlates of treatment outcomes, as well as 
the acceptability and feasibility of implementing CBT4CBT in a residential treatment program. 
Primary outcome variables were used for effect size estimations to determine the sample size 
needed for an adequately powered RCT of the intervention. The present study expanded on the 
current literature supporting the use of CBT4CBT in outpatient settings and provides benchmark 
data on the use of CBT4CBT in a residential treatment program for women with SUDs. This 
body of research has important implications for SUD treatment, with potential to expand the 
reach of evidence-based addiction treatment across different modalities and patient populations. 
 
 
 
 
 
  
 
1 
Introduction 
Addiction constitutes a major public health problem; one that costs the United States over 
$740 billion annually through health care costs, lost work productivity, and crime (NIDA, 2017). 
In 2015, an estimated 21.7 million people age 12 and older (8.1%) were in need of substance use 
treatment, defined as meeting criteria for having a substance use disorder (SUD) or receiving 
treatment at a specialty facility (NSDUH, 2015). Women represent a subpopulation of particular 
concern, as research has demonstrated an increased vulnerability among women for adverse 
medical and social consequences associated with substance use (Greenfield et al., 2007).  
Women have been found to progress more rapidly from regular use to first treatment episode 
compared to their male counterparts, a phenomenon known as telescoping (Greenfield et al., 
2007; Greenfield et al., 2010). Further, despite having used for fewer years at treatment entry, 
research has shown that women have more medical, psychiatric, and adverse social 
consequences on average compared to their male counterparts (Greenfield et al., 2007; 
Greenfield et al., 2010). 
Women with SUDs also face unique barriers to seeking and receiving substance use 
treatment (Terplan, Longinaker, & Appel, 2015; Greenfield et al., 2007; Green, 2006; Ashley, 
Marsden, & Brady, 2003). As a result, women are less likely to seek treatment than men. 
Gender-specific treatment programs seek to address such barriers, providing interventions 
tailored to deliver information and services to women, such as childcare assistance and housing 
(Greenfield et al., 2010; Claus et al., 2007). Research has found that women in such programs 
have higher retention rates, less drug use, and report fewer barriers to care (Terplan, Longinaker, 
& Appel, 2015). However, even in such programs, relapse rates remain high, with 40-60% of 
women relapsing (NIDA, 2014). 
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Cognitive behavioral treatment (CBT) is an evidence-based intervention for relapse 
prevention (McHugh, Hearon, & Otto, 2010; Hendershot et al., 2011). The CBT approach 
emphasizes the role of contextual factors (e.g, environmental stimuli and cognitive processes) as 
proximal relapse antecedents (Hendershot et al., 2011). CBT focuses on the identification and  
prevention of high-risk situations and relationships that increase patient risk for substance use 
(McHugh, Hearon & Otto, 2010). CBT seeks to improve the individual’s ability to cope with 
these high-risk situations that commonly lead to relapse (Sugarman, Nich, & Carroll, 2010). 
Through the use of CBT, patient cognitions around substance use are challenged (e.g., perceived 
benefits) and psychoeducation is provided to help the patient make a more informed choice when 
confronted with their cues for use.  In addition, CBT focuses on specific skills training and 
behavioral techniques to prevent substance use. CBT has been well supported in the literature 
(Dutra et al., 2008; Magill & Ray, 2009) and there has also been evidence of gender differences, 
with a recent meta-analysis demonstrating that women appeared to benefit more from CBT 
compared to men (Magill & Ray, 2009). 
The fact that CBT may particularly benefit women is consistent with other research 
showing that their reasons for relapse differ from men. Depression, interpersonal stress and 
relationship conflict are more likely to be associated with relapse in women (Tuchman, 2010). 
Further, research has shown that women are more likely to relapse when their romantic partners 
are substance users (Rubin, Stout, & Longabaugh, 1996); and women are more likely to report 
personal problems prior to relapse (McKay et al., 1996). Thus, the coping skills and stress 
management techniques in CBT may be central to relapse prevention among women.  
Despite its effectiveness, CBT is rarely implemented in community-based treatment 
(IOM, 1998). This is due to a range of barriers, including limited availability of professional 
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training in CBT (Weissman et al., 2006), high rates of clinician turnover (McLellan, Carise, & 
Kleber, 2003), complexity and cost of training clinicians (Sholomskas et al., 2005; Morgenstern 
et al., 2001), high caseloads and limited resources (McLellan & Meyers, 2004). Evidence 
suggests that only a minority of individuals in need of addiction and other psychiatric services 
receive evidence-based treatment (IOM, 1998). Further, although many clinicians report using 
CBT techniques in their practice, they tend to overestimate their use of CBT and other 
empirically supported therapies (Carroll et al., 2008). 
Computer-assisted delivery of CBT offers an opportunity to improve the quality and 
reach of treatment services that is both feasible and cost-effective (Carroll et al., 2014). 
Computer-assisted therapy provides a platform for teaching CBT skills to patients that enables 
clinicians to focus on acute concerns and problems (Carroll et al., 2008). Further, the 
computerized format standardizes treatment delivery, providing a more consistent, and 
potentially more effective, method of teaching and demonstrating CBT skills than is available in 
clinical settings. Computer-assisted delivery of CBT presents the information via a range of 
media (text, video, interactive exercises) and allows participants to select or tailor the content 
based on their specific needs.  Studies to date have demonstrated the utility of CBT4CBT in 
outpatient settings, with individuals randomized to CBT4CBT exhibiting better outcomes, 
including more negative urine specimens, longer periods of abstinence, better durability of 
effects over time (Carroll et al., 2014; Carroll et al., 2009; Carroll et al., 2008; Kiluk et al., 2016) 
and improved coping skills compared to treatment as usual (TAU) (Kiluk et al., 2010; Sugarman 
et al., 2010). Coping strategies have been identified as a potential predictor of such outcomes. 
For example, studies have found participants in the CBT4CBT condition showed greater 
improvements in both the use (Sugarman et al., 2010) and quality of coping skills (Kiluk et al., 
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2010) compared to TAU. Further, increases in coping strategy use were associated with 
decreases in drug use (Sugarman et al., 2010), and the quality of coping responses mediated the 
effect of treatment on participants’ duration of abstinence following treatment (Kiluk et al., 
2010).  
Although CBT4CBT has demonstrated effectiveness in outpatient settings, it has not yet 
been evaluated as an adjunct to residential treatment for SUDs. The present study conducted a 2-
arm randomized clinical trial (RCT) comparing post-discharge relapse rates for TAU with access 
to the CBT4CBT program (CBT4CBT; intervention) vs. treatment as usual (TAU; control) in a 
residential sample of women with SUDs. All women completed a baseline assessment, followed 
by random assignment to either CBT4CBT or TAU. Women in the CBT4CBT condition had 
access to the CBT4CBT program throughout their residential stay. Follow-up assessments 
occurred at discharge, with weekly smartphone assessments during weeks 1-3 post-discharge, 
and in-person assessments at 4 and 12 weeks following residential treatment (see Table 1 for 
assessment schedule). Primary outcome measures included: 1) relapse Y/N (any alcohol/drug 
use) in the 12 weeks post-discharge; 2) number of days of substance use in the 12-weeks post-
residential care; and 3) coping strategies score, as measured by the Coping Strategies Scale 
(CSS; Litt et al., 2008; Sugarman et al., 2010). Other psychosocial variables (e.g., depression, 
stress) were also examined to identify correlates of observed treatment outcomes. 
 Specific Aim 1: Examine feasibility for use of CBT4CBT in a residential treatment 
program for women with SUDs, as well as follow-up rates, methods, effect size, and sample size 
estimates to power a larger RCT. 
  
 
5 
   Specific Aim 2: Conduct a small RCT comparing TAU with access to the CBT4CBT 
program (CBT4CBT; intervention) vs. treatment as usual (TAU; control) using relapse rates and 
days of use as primary treatment outcomes. 
Hypothesis 1: Women in the CBT4CBT group will be less likely to relapse (Y/N) during 
the 12-week follow-up period than women in TAU.  
   Hypothesis 2: Women in the CBT4CBT group will report fewer days of substance use 
compared to women in TAU during the 12-week follow-up period. 
Sub-aim 2a: CBT4CBT and TAU will also be compared on time to first substance use 
(survival analysis) during the 12 weeks post-discharge.  
Specific Aim 3: Longitudinally examine correlations between CBT4CBT and the use of 
coping strategies (baseline, discharge, and 12-week follow-up) and associations between coping 
strategies and substance use, as well as other treatment outcomes.  
Hypothesis 3: Women in the CBT4CBT group will have higher coping scores over time 
compared to TAU; higher coping scores will be associated with lower risk of relapse. 
Specific Aim 4: Conduct exploratory analyses to identify other correlates (e.g., 
depression, stress) of relapse at 4 and 12-weeks post-discharge. 
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Review of the Literature 
Addiction is a chronic, relapsing disorder that is characterized by compulsive drug 
seeking and continued use, despite harmful outcomes. Negative consequences of substance use 
disorders (SUD) include medical conditions, such as cardiovascular disease, stroke, cancer, as 
well as psychosocial impairment (NIDA, 2014). Addiction constitutes a major public health 
problem; one that costs the United States over $740 billion annually through health care costs, 
lost work productivity, and crime (NIDA, 2017). In 2015, an estimated 21.7 million people age 
12 and older (8.1%) were in need of substance use treatment, defined as meeting criteria for 
having a SUD or receiving treatment at a specialty facility (NSDUH, 2015). However, only 11% 
of those in need of services received substance use treatment at a specialty facility. Thus, the 
majority of persons with heavy/problem alcohol or drug use are not actively engaged in 
traditional substance abuse treatment.   
Women and Substance Use Treatment 
Women represent a subpopulation of particular concern, as research has demonstrated an 
increased vulnerability among women for adverse medical and social consequences associated 
with substance use (Greenfield et al., 2007).  Women have been found to progress more rapidly 
from regular use to first treatment episode compared to their male counterparts, a phenomenon 
known as telescoping (Greenfield et al., 2007; Greenfield et al., 2010). Further, despite having 
used for fewer years at treatment entry, research has shown that women have more medical, 
psychiatric, and adverse social consequences on average compared to their male counterparts 
(Greenfield et al., 2007; Greenfield et al., 2010). 
Women also face unique barriers to seeking and receiving substance use treatment 
(Terplan, Longinaker, & Appel, 2015; Polak et al., 2015; Greenfield et al., 2007; Green, 2006; 
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Ashley, Marsden, & Brady, 2003). Barriers include social stigma, pregnancy, domestic violence, 
lack of childcare, and fear of legal consequences (Terplan, Longinaker, & Appel, 2015; Andrews 
et al., 2011; Laudet, Stanick, & Sands, 2009; Greenfield et al., 2007). Further, these barriers are 
often more prevalent among women with SUDs. For example, the prevalence of intimate partner 
violence ranges from 10-30% in the general population, while estimates range from 25-60% 
among substance-using women (Andrews et al., 2011). There are also higher rates of certain co-
occurring mental health conditions in women compared to men, such as mood, eating, anxiety, 
and post-traumatic stress disorder, which serve as additional barriers to receiving appropriate 
services (Greenfield et al., 2007). Lastly, a history of sexual or physical trauma may make 
certain treatment approaches or mixed-gender treatment facilities less desirable for women to 
seek care at such programs (Greenfield et al., 2007). As a result of these barriers, early research 
demonstrated that women were less likely to seek treatment for substance use compared to men 
with similar problem severity (Terplan, Longinaker, & Appel, 2015; Andrews et al., 2011; 
Laudet, Stanick, & Sands, 2009; Green, 2006). 
In response to this research, efforts were made to address such barriers with gender-
specific treatment programs, providing interventions tailored to deliver information and services 
to women (Greenfield et al., 2010; Claus et al., 2007). Many treatment programs provide either 
gender-specific services, such as gender-specific treatment groups and content, or integrate 
gender-sensitive approaches more broadly into their curriculum, such as gender-matching with 
counselors and mixed-gender treatment groups led by male and female co-leaders (Green, 2006). 
Many treatment programs also provide services to minimize barriers to care, such as childcare, 
transportation, and housing (Greenfield et al., 2010; Claus et al., 2007; Green, 2006). Following 
the introduction of gender-specific treatment programs, research has found that women in such 
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programs have higher retention rates, less substance use, and report fewer barriers to care 
(Grella, 2008; Campbell et al., 2005; Hser et al., 2011; Ashley et al., 2003).  
Despite these advances, relapse rates remain a central concern of addiction, with 
approximately 40-60% of patients relapsing following treatment (NIDA, 2014). Relapse was 
traditionally conceptualized as any substance use following a period of abstinence; however, in 
recent years the definition of relapse has shifted to a more dimensional approach in an effort to 
account for the variability of the relapse process (Brandon et al., 2007). As a result, greater 
emphasis has been placed in differentiating between a lapse, often referred to as a ‘slip’, and a 
full relapse. A lapse refers to a brief episode of substance use in which the individual quickly 
stops afterward and returns to recovery. A relapse, however, refers to the resumption of 
extended, problematic use. 
Cognitive Behavioral Therapy 
Cognitive-behavioral therapy (CBT) is a goal-oriented short-term intervention that posits 
targeting maladaptive thoughts and beliefs can lead to changes in emotional distress and problem 
behaviors (Beck, 1970; Ellis, 1962; Hofman et al., 2012). It is based on the premise that 
maladaptive cognitions play a key role in the maintenance of emotional distress and behavioral 
problems. CBT takes a collaborative approach in which the patient plays an active role in testing 
and challenging their thoughts and behaviors. It represents one of the most studied forms of 
psychotherapy and has been applied to a range of disorders, including depression, anxiety, 
addiction and substance use disorders, bipolar disorder, schizophrenia and other psychotic 
disorders, somatoform disorders, eating disorders, insomnia, personality disorders, anger and 
aggression, criminal behaviors, general stress, distress due to medical conditions, chronic pain 
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and fatigue, pregnancy complications and hormonal conditions (Hofman et al., 2012; Butler et 
al., 2006).    
CBT for treatment of SUDs focuses on the identification and prevention of high-risk 
situations and relationships that increase patient risk for substance use (McHugh, Hearon & Otto, 
2010). CBT emphasizes the role of contextual factors (e.g, environmental stimuli and cognitive 
processes) as proximal relapse antecedents (Hendershot et al., 2011). A high-risk situation refers 
to any circumstance in which an individual’s efforts to abstain from substance use are threatened, 
such as specific people (e.g., drug dealers), places (e.g., liquor store), and events (e.g., parties) 
(Witkiewitz & Marlatt, 2004). Through the use of CBT, patient cognitions around substance use 
are challenged (e.g., perceived benefits) and psychoeducation is provided to help the patient 
make a more informed choice when confronted with their cues for use. In addition, CBT focuses 
on specific skills training and behavioral techniques to prevent substance use. Refusal skills are 
taught through demonstrations and role-playing, as well as coping strategies (e.g., diaphragmatic 
breathing). 
CBT for SUDs has been supported in meta-analytic reviews, with effect sizes in the small 
to moderate range using heterogeneous comparison conditions (Dutra et al., 2008; Magill & Ray, 
2009), and larger effect sizes when compared to a no-treatment control (Magill & Ray, 2009). 
Treatment effects for CBT have been found to decrease over time, with diminishing effect sizes 
across the 6- 9- and 12-month follow-up visits (Magill & Ray, 2009). Further, there has been 
evidence of gender differences, with a recent meta-analysis demonstrating that women appeared 
to benefit more from CBT compared to men (Magill & Ray, 2009). 
The fact that CBT may particularly benefit women is consistent with other research 
showing that female reasons for relapse differ from those for males. Depression, interpersonal 
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stress, relationship conflict (Tuchman, 2010), personal problems (McKay et al., 1996), and low 
mood (Messer et al., 2018) are more likely to be associated with relapse in women than in men. 
Further, research has shown that women are more likely to relapse when their romantic partners 
are substance users (Rubin, Stout, & Longabaugh, 1996). Taken together, the coping skills and 
stress management techniques in CBT may be central to relapse prevention among women. 
CBT Dissemination 
While recognized as an evidence-based practice (EBP), efforts to disseminate and 
implement CBT in community-based treatment have had only limited success. One promising 
opportunity for improvement came through the National Drug Abuse Treatment Clinical Trials 
Network (CTN), whose mission was to improve the translation of science-based addiction 
treatments into clinical practice (Tai et al., 2010). The CTN brought together academic 
researchers and SUD treatment providers to develop and implement provider-informed clinical 
trials in community-based treatment programs (Donovan et al., 2011). The partnership promoted 
reciprocal exchange of ideas, with researchers able to address practice-relevant questions, while 
also fulfilling the practical needs of those providing SUD treatment services. However, even this 
large-scale effort resulted in limited success in the dissemination of EBPs. In fact, a prominent 
CTN study examining audiotapes of what constituted standard practice across nine community-
based treatment programs found that the only EBPs consistently present were those associated 
with basic MI skills (e.g., open-ended questions, reflective listening) (Santa Ana et al., 2008). 
While program directors and clinicians had indicated they frequently used evidence-based 
approaches, particularly CBT, these interventions were largely absent from the taped sessions.   
One of the primary barriers to the dissemination of EBTs has been the time and cost of 
the clinical training required to deliver these interventions effectively. Clinical training programs 
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(e.g., psychiatric residencies, clinical psychology doctoral programs, PsyD programs, and social 
work) provide one opportunity to teach EBPs in advance of entry into clinical practice 
(Weissman et al., 2006). The combination of didactic training with clinical supervision is often 
considered the gold standard of learning a new treatment (Weissman et al., 2006). However, a 
national survey of training programs found that while a range of psychotherapy electives were 
offered across clinical training programs, they were mostly non-EBT’s and often did not require 
supervision. While CBT was among the most frequently offered EBT across the surveyed 
disciplines, training in this treatment without supervision has been found to be largely 
ineffective, with Scholomskas and colleagues (2005) finding that only 15% of clinicians 
demonstrated adequate CBT skills following manual-based training compared to 54% of 
clinicians assigned to the seminar plus supervision training condition. As a result, even when 
clinicians have received training, the subsequent fidelity with which they are delivered can vary 
greatly across programs and therapists (Marsch, Carroll & Kiluk, 2014). Clinicians have also 
been found to overestimate their use of EBTs compared to what is actually delivered in practice 
(Carroll, Martino & Rounsaville, 2010). Moreover, while most mental health counseling 
practices require therapists trained at the masters-level, the field of SUD treatment has no such 
requirement (Sias, Lambie & Foster, 2006).  Many counselors working in community-based 
substance abuse treatment programs have not completed their bachelor’s or master’s degree 
training and have varying levels of exposure to empirically supported treatments (Sholomskas et 
al., 2005).  
Larger systemic barriers have also been identified as limiting the dissemination of EBTs. 
Training in CBT is relatively expensive and time intensive and may not be feasible for 
institutions to provide adequate training for their clinicians (Sholomskas et al., 2005). Further, a 
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national survey of substance abuse treatment programs found high staff turnover rates among 
clinicians and program directors, with over half of the program directors having been in their 
jobs for less than one year (53%) (McLellan, Carise & Kleber, 2003). One sixth of the programs 
had either closed or ceased providing addiction treatment, programs were understaffed, had 
limited resources to meet their needs (e.g., computers), and one sixth had either closed or ceased 
providing addiction treatment. Thus, many treatment programs do not have the sustainability and 
resources required to successfully integrate EBTs into their curriculum. 
As a result of these barriers, there continues to be a disconnect between behavioral and 
pharmacological treatments supported in the literature and those delivered in practice (Padwa & 
Kaplan, 2018). Current estimates indicate that less than half of SUD treatment programs deliver 
EBT to their patients (Molfenter, 2014; Saunders & Kim, 2013). Instead, widely accepted 
treatments that lack empirical support continue to be implemented in practice. For example, 
many substance use programs include educational lectures and films in their curriculum, while 
research has demonstrated no effect of such approaches. Similarly, acupuncture, confrontational 
therapeutic styles, insight-oriented psychotherapy, or mandatory attendance of Alcohol 
Anonymous still enjoy widespread use despite controlled trials showing little to no benefit of 
such approaches. This may reflect a tendency of practitioners to continue doing what is familiar 
and comfortable in their clinical practice, as well as current research being published in outlets 
and forums that may be inaccessible to busy clinicians (Miller et al., 2006). 
Technology-Based Interventions 
Technology has been identified as one strategy to address barriers to care and improve 
the reach of EBTs. Early research has highlighted a number of advantages of technology-based 
interventions, including low cost, standardized treatment delivery, longer therapeutic contact, 
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greater confidentiality, increased flexibility and convenience, and increased opportunities for 
practicing skills (Moore et al., 2011; Marsch, Carroll & Kiluk, 2014). Technology offers a 
platform to disseminate EBTs that improves treatment fidelity without increasing demands or 
training needs of the health care professionals (Marsch, Carroll & Kiluk, 2014). Technology-
based interventions have been conceptualized as “clinician extenders,” offering access to 
therapeutic services when patients are not engaged in clinical interactions, and more broadly, 
technology may serve as a means of disseminating EBTs beyond what is possible in the current 
model of care.  
Computer-based interventions have been shown to be effective across a number of 
disorders, including depression, anxiety, diabetes, poor nutrition, and sexual risk behaviors 
(Moore et al., 2011). A range of computer and Internet-based programs for SUDs has also been 
developed in recent years and demonstrated positive treatment outcomes. Computer-based 
interventions for alcohol use have been found to significantly improve alcohol use outcomes 
compared to no treatment and assessment only interventions (Carey et al., 2009; Elliott, Carey & 
Bolles, 2008). For tobacco, meta-analyses have demonstrated abstinence rates from computer-
based interventions are approximately 1.5 times higher than control conditions (Myung et al., 
2009). Similarly, a recent review found computer-based interventions for other drug use led to 
less substance use, higher motivation to change, better retention, and greater knowledge of the 
presented information, compared to treatment as usual (Moore et al., 2011). Further, recent 
research comparing computerized and in-person interventions found comparable outcomes 
across conditions (Schwartz et al., 2014), with treatment gains maintained through twelve 
months of follow-up (Gryczynski et al., 2015) 
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This exciting body of research also parallels the technology revolution, offering a 
medium of treatment delivery that will be widely accessible. As of 2018, an estimated 95% of 
Americans own a cellphone of some kind, with 77% owning smartphones (Pew Research Center, 
2018). Internet and mobile access also continues to grow, providing a platform capable of 
providing service to traditionally underserved and vulnerable populations, such as individuals 
with SUDs (Marsch, Carroll & Kiluk, 2014). Thus, technology offers a means of providing 
treatment that will be readily accessible to those in need, limiting barriers to receiving substance 
use treatment. 
Computer-Assisted Delivery of CBT  
One of the most prominent computer-based interventions for substance use disorders 
provides computer-assisted delivery of CBT, known as CBT4CBT. CBT4CBT consists of seven 
modules based on the NIDA-published CBT manual (Carroll, 1998). CBT4CBT provides a 
platform for teaching CBT skills to patients that enables clinicians to focus on acute concerns 
and problems (Carroll et al., 2008). Further, the computerized format standardizes treatment 
delivery, providing a more consistent, and potentially more effective, method of teaching and 
demonstrating CBT skills than is available in clinical settings. CBT4CBT presents the 
information via a range of media (text, video, interactive exercises) and allows participants to 
select or tailor the content based on their specific needs.   
Studies to date have demonstrated the utility of CBT4CBT as an adjunct to addiction 
treatment in outpatient settings. The first randomized clinical trial of CBT4CBT examined the 
program as an adjunct to standard addiction treatment compared to treatment as usual (TAU) 
among 77 individuals seeking treatment at an outpatient community program for a range of 
SUDs (Carroll et al., 2008). Primary substances included alcohol, cocaine, marijuana, and 
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opioids, with the majority of participants reporting polysubstance use (80%). The trial lasted 
eight weeks and women in the CBT4CBT condition accessed the program biweekly. Participants 
in the CBT4CBT submitted significantly more negative urine specimens and tended to have 
longer continuous periods of abstinence compared to the TAU condition. A follow-up study 
examined the durability of these effects at a 6-month follow-up visit, and with 82% of the sample 
contacted for follow-up, the CBT4CBT condition demonstrated significantly better treatment 
outcomes compared to TAU for both self-reported substance use, as well as urinalysis (Carroll et 
al., 2009).  
Building upon these early findings, a second, larger RCT was conducted in 101 cocaine-
dependent methadone-maintained individuals (Carroll et al., 2014). This patient population was 
chosen in an effort to examine the CBT4CBT program in a more homogeneous patient 
population. Participants were again randomized to either standard methadone maintenance 
(TAU) or standard care with weekly access to the CBT4CBT program. Participants in the 
CBT4CBT condition were significantly more likely to attain 3 or more consecutive weeks of 
abstinence within treatment compared to TAU. Further, data from the 6-month follow-up visit 
demonstrated continued improvements, with the CBT4CB condition showing a greater reduction 
in cocaine use compared to TAU, further supporting the durability of the program’s effects. 
Next, an RCT was conducted among 68 individuals seeking treatment for alcohol use 
disorder at a community outpatient facility (Kiluk et al., 2016). This study expanded upon 
existing research and randomized participants to one of three conditions: 1) standard TAU; 2) 
TAU plus on-site access to the CBT4CBT program (TAU+CBT4CBT); or 3) CBT4CBT plus 
brief weekly clinical monitoring (CBT4CBT+monitoring). There were higher rates of treatment 
retention in both of the CBT4CBT conditions. Significant reductions in alcohol use were found 
  
 
16 
across all treatment conditions, with participants in TAU+CBT4CBT showing greater increases 
in percent days abstinent compared to TAU, and comparable outcomes across TAU and 
CBT4CBT delivered with clinical monitoring only. Further, when examining costs across the 
treatment conditions, TAU was substantially higher (approximately 4 times) compared to either 
of the CBT4CBT conditions. 
The most recent RCT of CBT4CBT examined the intervention as a stand-alone treatment 
in 137 treatment-seeking outpatients with SUDs (Kiluk et al., 2018). Participants were 
randomized to receive TAU, weekly individual CBT, or CBT4CBT with brief weekly 
monitoring. Participants in both the CBT and CBT4CBT conditions reduced the frequency of 
their substance use significantly more compared to TAU. Further, participants in the CBT4CBT 
condition demonstrated maintained treatment gains at the six-month follow-up visit compared to 
TAU. Clinician-delivered CBT was unexpectedly associated with higher dropout rate and lower 
effects at follow-up. This trial represented the first study to support CBT4CBT as a stand-alone 
intervention in an outpatient setting.  
In addition to these early RCTs on CBT4CBT, there has been limited research examining 
characteristics associated with the observed treatment outcomes.  Coping strategies have been 
identified as a potential predictor of treatment outcomes. For example, studies have found 
participants in the CBT4CBT condition showed greater improvements in both the use (Sugarman 
et al., 2010) and quality of coping skills (Kiluk et al., 2010) compared to TAU. Further, increases 
in coping strategy use were associated with decreases in drug use (Sugarman et al., 2010), and 
the quality of coping responses mediated the effect of treatment on participants’ duration of 
abstinence following treatment (Kiluk et al., 2010). While the CBT literature more broadly has 
been mixed regarding the role of coping strategies in treatment outcomes (Morgenstern et al., 
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2010; Litt et al., 2003; Litt et al., 2008), the level of standardization associated with CBT4CBT 
may offer an opportunity to gain a clearer understanding of this relationship (Sugarman et al., 
2010). IQ has also been identified as influencing this relationship, with individuals with higher 
IQ at baseline improving the quality of their coping skills more than those with a lower IQ 
(Kiluk et al., 2011). Lastly, engagement with the CBT4CBT program has been identified as 
influencing treatment outcomes, with more completed modules and homework assignments 
associated with greater reductions in substance use (Carroll et al., 2008), affirming the 
importance of treatment dose (e.g., number of sessions). 
Taken together, CBT4CBT has been well supported in outpatient treatment programs. 
However, to-date this innovative therapy has not been evaluated in an inpatient setting. Further, 
CBT4CBT has not been evaluated specifically in women, a population that may particularly 
benefit from the treatment program. 
Statement of the Problem  
 Women represent a population of particular concern in the field of addiction, as research 
has demonstrated an increased vulnerability for adverse medical and social consequences 
associated with substance use (e.g., Polak et al., 2016). Further, women have been found to 
progress more rapidly from regular use to first treatment episode compared to their male 
counterparts (Greenfield et al., 2007; Greenfield et al., 2010). Women with substance use 
disorders (SUD) also face unique barriers (e.g., childcare) to seeking and receiving substance use 
treatment (Terplan, Longinaker, & Appel, 2015; Greenfield et al., 2007; Green, 2006; Ashley, 
Marsden, & Brady, 2003). Gender-specific treatment has sought to address such barriers, 
resulting in higher retention rates, less drug use, and improved access (Terplan, Longinaker, & 
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Appel, 2015). Despite these improvements, relapse rates remain high, 40-60% of women 
relapsing following treatment (NIDA, 2014). 
 Cognitive behavioral treatment (CBT) is an evidence-based intervention for relapse 
prevention that emphasizes the role of contextual factors (e.g., environmental stimuli and 
cognitive processes) as proximal relapse antecedents (McHugh, Hearon, & Otto, 2010; 
Hendershot et al., 2011). CBT seeks to improve the individual’s ability to cope with these high-
risk situations that commonly lead to relapse (Sugarman et al., 2010). CBT has been well 
supported in the literature and there has also been evidence of gender differences, with a recent 
meta-analysis demonstrating that women appeared to benefit more from CBT compared to men 
(Magill & Ray, 2009). This is consistent with other literature suggesting women’s reasons for 
relapse differ from men, with depression, interpersonal stress, relationship conflict (Tuchman, 
2010), personal problems (McKay et al., 1996), and low mood (Messner et al., 2018) more likely 
to be associated with relapse in women. Despite its effectiveness, CBT is rarely implemented in 
community-based treatment (IOM, 1998) due to a range of barriers, including limited availability 
of professional training in CBT (Weissman et al., 2006), high rates of clinician turnover 
(McLellan, Carise, & Kleber, 2003), complexity and cost of training clinicians (Sholomskas et 
al., 2005; Morgenstern et al., 2001), high caseloads and limited resources (McLellan & Meyers, 
2004). 
Computer-assisted delivery of CBT (CBT4CBT) offers an opportunity to improve the 
quality and reach of treatment services that is both feasible and cost-effective. CBT4CBT 
provides a platform for teaching CBT skills to patients that enables clinicians to focus on acute 
concerns and problems (Carroll et al., 2008). Further, the computerized format standardizes 
treatment delivery, providing a more consistent, and potentially more effective, method of 
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teaching and demonstrating CBT skills than is available in clinical settings. Studies to date have 
demonstrated the utility of CBT4CBT as an adjunct to addiction treatment in outpatient settings 
(Carroll et al., 2008; Carroll et al., 2014; Kiluk et al., 2016; Kiluk et al., 2018), with individuals 
randomized to CBT4CBT having better outcomes, including more negative urine specimens, 
longer periods of abstinence, better durability of effects over time (Carroll et al., 2014; Carroll et 
al., 2009; Carroll et al., 2008; Kiluk et al., 2016) and improved coping skills compared to 
treatment as usual (TAU) (Kiluk et al., 2010; Sugarman et al., 2010). Coping strategies have 
been identified as a potential predictor of such outcomes, with research demonstrating that 
participants in the CBT4CBT condition showed greater improvement in both the use and quality 
of their coping skills compared to TAU (Kiluk et al., 2010; Sugarman et al., 2010). Further, 
increases in coping strategy use were associated with decreases in drug use (Sugarman et al., 
2010), and the quality of coping responses mediated the effect of treatment on participants’ 
duration of abstinence following treatment (Kiluk et al., 2010). 
While CBT4CBT has been supported in outpatient settings, it has not yet been evaluated 
as an adjunct to residential treatment. Specific aims for the study were to: 1) examine feasibility 
for use of CBT4CBT in a residential treatment program for women with SUDs, as well as 
follow-up rates, methods, effect size, and sample size estimates to power a larger RCT; 2) 
conduct a small RCT comparing TAU with access to the CBT4CBT program (CBT4CBT; 
intervention) vs. treatment as usual (TAU; control) using relapse rates and days of use as primary 
treatment outcomes; 3) longitudinally examine correlations between CBT4CBT and the use of 
coping strategies (baseline, discharge, and 12-week follow-up) and associations between coping 
strategies and substance use, as well as other treatment outcomes; and 4) conduct exploratory 
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analyses to identify other correlates (e.g., depression, stress) of relapse at 4 and 12 weeks post-
discharge. 
Statement of Hypotheses 
 Based on the literature and study aims, the following hypotheses were tested: 
1) Women in the CBT4CBT group will be less likely to relapse (Y/N) during the 12-
week follow-up period than women in TAU. 
   2) Women in the CBT4CBT group will report fewer days of substance use compared to 
women in TAU during the 12-week follow-up period. 
3) Women in the CBT4CBT group will have higher coping scores over time compared to 
TAU; higher coping scores will be associated with lower risk of relapse. 
In addition, qualitative data was collected to examine the feasibility and acceptability of 
the CBT4CBT program in a residential treatment setting, including perceptions of the program, 
as well as barriers and facilitators to implementation.  
Method 
Objectives of Study 
 The primary goal of this study was to test a computer-based cognitive behavioral therapy 
program (CBT4CBT) as an adjunct to residential treatment. This study was approved by Virginia 
Commonwealth University’s Institutional Review Board under “A Randomized Trial of 
CBT4CBT for Women in Residential Treatment for Substance Use Disorders,” protocol number 
HM20012674. 
Study Site 
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 RBHA North Campus (RBHA-NC), formerly known as Rubicon Inc., was reopened 
under new management in 2018 to reestablish addiction treatment services for women with 
substance use disorders and co-occurring mental health conditions in Richmond, Virginia and 
surrounding areas. The large non-profit organization provides substance abuse treatment services 
through a 57-bed residential program, including medication education and management, 
individual and group counseling, and case management for patient needs such as housing, 
transportation, and childcare. Counseling services cover a range of topics, including relapse 
prevention, re-entry skills, health and wellness, relationships, anger and conflict management, 
leadership skills, domestic violence, sexual abuse, and parenting.  
 Based on the patient SUD severity and the number and nature of comorbid conditions, 
RBHA-NC program offers two levels of care, the 3.5 level offers high intensity residential 
services for women with greater medical and psychosocial needs such as criminal activity, 
serious mental health conditions, and/or impaired functioning. This level of care provides a 
stable living environment where women can develop and implement sufficient recovery skills 
before reengaging in day-to-day activities outside of the treatment program. Treatment activities 
include: a range of evidence-based cognitive, behavioral, and other therapies in individual and 
group formats; medication education and management; educational skill building groups; and 
occupational or recreational activities. Women in the 3.5 level of care have highly structured 
treatment plans held exclusively at the RBHA-NC facility or facilitated within the community by 
the program (e.g., 12-step meeting) in order to practice and integrate their coping skills in a 
supportive and more controlled environment.  Treatment plans are individualized, with treatment 
goals and overall length of stay determined by patient needs. The 3.5 level of care is viewed as 
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one part of the recovery process, with many resident treatment plans including a step down to a 
lower level of care (e.g., 3.1 level and/or intensive outpatient services) when clinically indicated. 
 The 3.1 level of care at RBHA-NC offers low intensity residential services designed for 
women who still need time and structure to practice their recovery and coping skills, while 
working to reintegrate and engage in day-to-day activities outside the program. Women in this 
level of care require a minimum of 5 hours per week of clinical and/or structured support 
services. They often receive vocational and housing services, as well as groups focused on 
personal health and wellness with the goal of establishing and maintaining independent living 
within the community. Random drug screenings are used to monitor and reinforce treatment 
gains. Women in this level of care often step down to outpatient services and/or 12-step meetings 
following their discharge from residential care. 
Participants 
 Participants were recruited in-person by the principal investigator (PI) or RAs, who were 
unaffiliated with the RBHA-NC treatment program. Women were approached within the first 
few days of residential treatment and asked if they were interested in participating in a study 
examining a computer-based cognitive behavioral therapy program as an adjunct to treatment.  
Recruitment. Recruitment occurred at RBHA-NC, a residential women’s substance 
abuse treatment facility, from October 4, 2018 through August 30, 2019. Recruitment procedures 
were based on those used successfully in four previous RCTs at RBHA-NC (Svikis et al., 2007; 
Langhorst et al., 2012; Choi et al., 2011; Meshberg-Cohen et al., 2014; Islam & Svikis, 2015). 
The PI or RA worked closely with site staff to identify potential participants with minimal 
disruption to clinical care. Identified residents were asked to report to the Staff on Duty (SOD) 
office to meet with the PI or RA and screened for eligibility.  
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Inclusion criteria. Eligibility criteria for study participation included:1) ≥18 years of 
age; 2) female; 3) meet DSM-5 criteria for a SUD (current); 4) recommended residential stay 
≥3.5 weeks; 5) own a smartphone; and 6) able to return to facility for the 4 and 12-week follow-
up visits.  
Exclusion criteria. Women were ineligible to participate if they were currently pregnant 
or presented with a serious cognitive or psychiatric impairment, or language barriers that 
prevented them from giving true informed consent. Pregnant women were excluded because 
their length of stay was likely to vary compared to non-pregnant women and they also may be 
discharged early for medical reasons associated with their pregnancy.  
*Note: Inclusion criteria were broadened to include patients who did not have a phone at time of 
treatment admission but had plans of obtaining one during their residential stay. This expansion 
in inclusion criteria was prompted by low rates of patient eligibility, with many women obtaining 
a phone over the course of their treatment. Further, in the event women were unable to complete 
the 4 and 12-week follow-up visits in person (e.g., moved away, limited transportation), the 
assessments were completed over the phone. These changes were made to maximize study 
enrollment and follow-up data collection. 
Sample size. A statistical power analysis was performed for study sample size 
calculation. Previous CBT4CBT studies have demonstrated moderate to large effect sizes (.45-
1.21) across outpatient settings when evaluated as an adjunct to standard care and compared to a 
treatment as usual control group (Carroll et al., 2014; Shi et al., 2019; Cohen et al., 2003), 
Accordingly, a sample size calculation (2-tailed test,  = .05, power of 80%) assuming equal 
variance and equal n in the 2 groups to detect a large effect size (d = 0.8) determined that N=26 
per group (N=52 total) was sufficient for the study (Cohen et al., 2003). However, to allow for 
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dropouts and to increase power, we planned to enroll 35 patients per group (N=70) and estimated 
we would enroll 6-7 women/month (N=70 over 10 months) with 85% (N=60) completing the 4 
and 12-week follow-ups. The present study sought to collect pilot data to inform a future R01 
grant application. 
Study Procedures 
Screening and consent. Women who met preliminary screening criteria (age, not 
pregnant, own a smartphone) were invited to participate in an RCT for relapse prevention. 
Women were given a VCU IRB-approved consent form, which was summarized aloud by the 
RA/PI. Potential participants were told that study participation would include a 90-minute 
baseline visit followed by randomization to either TAU with access to the CBT4CBT program 
(CBT4CBT; intervention) or TAU (TAU; control). Residents were told that if assigned to the 
CBT4CBT group, they would be given access to the program for a minimum of two 1-hour 
sessions per week to aid in their completion of the seven CBT4CBT modules. Potential 
participants were informed that regardless of group assignment, they would be asked to complete 
study assessments in person at discharge, followed by weekly smartphone assessments during 
weeks 1-3 post-discharge from residential care, and in-person at 4- and 12-weeks post-discharge. 
Potential participants were informed that they could receive up to $130 in gift cards if they 
completed all research assessments. All of the women were encouraged to ask questions and 
assured that a decision not to participate in the study would in no way affect their care at RBHA-
NC. Potential participants were also assured that study data would not be shared with RBHA-NC 
staff. Women who chose to participate were asked to sign a VCU IRB-approved consent form 
and scheduled for a baseline visit. The participant was offered a copy of the consent document 
and the original was retained by the research team in a locked filing cabinet on-site. 
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 Baseline assessment. Assessment measure administration schedule is summarized in 
Table 1. The baseline assessment battery consisted of twelve measures (summarized below) that 
were administered by the RA or PI in a private setting at RBHA-NC. The baseline assessment 
took approximately 90 minutes and was completed over one to two sessions. Study participants 
were reminded that study data would not be shared with RBHA-NC staff and they would receive 
a $20 gift card upon completing the assessment.   
Demographics. Demographic variables included age, race/ethnicity, marital status, 
education, employment, income and insurance coverage. 
Addiction Severity Index (ASI; McLellan et al., 1980; McLellan et al., 1992). The 
Addiction Severity Index was used to evaluate domains commonly affected by substance use, 
including medical, employment/self-support, alcohol, drug, legal status, family-social 
environment, and psychiatric status. The ASI requires 45 minutes to administer and has 
demonstrated excellent reliability and validity (Makela, 2004). The PI completed ASI training 
and completed all ASI baseline assessments with back up and supervision from Dr. Svikis. The 
full ASI was administered at baseline, with a subset of items re-administered at the 12-week 
follow-up to examine changes in psychosocial functioning from baseline to follow-up.  
Mini-International Neuropsychiatric Interview (MINI; Sheehan et al., 1997). The 
MINI is a brief structured diagnostic interview for the assessment of substance use disorders and 
other psychiatric disorders. The MINI was developed jointly by psychiatrists and clinicians in the 
United States and Europe in an effort to provide a tool that can provide brief and accurate 
assessment of psychiatric disorders that was compatible with international diagnostic criteria, 
including the Diagnostic and Statistical Manual of Mental Disorders (DSM-5; APA, 2013) and 
International Classification of Diseases codes (ICD-10; World Health Organization, 1993). The 
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MINI has demonstrated good reliability and validity for SUD diagnoses (Sheehan et al., 1998; 
Lecrubier et al., 1997; Sheehan et al., 1997). The alcohol and drug use sections of the MINI 
required 20-30 minutes to administer and were done by either the PI or RA, as trained lay 
interviewers who do not have a clinical background are able to administer the MINI. Select 
modules, including alcohol use disorder and substance use disorder (non-alcohol), were 
administered only at baseline to confirm diagnosis of a substance use disorder.  
Timeline Follow Back (TLFB; Sobell & Sobell, 1992). The TLFB is a semi-structured, 
calendar-based interview used to collect retrospective estimates of daily substance use over a 
specified time period. Memory aids are used to enhance participant recall. The TLFB has been 
shown to have high test-retest reliability (ICC values ranging from .70 to.94, with all p<0.001), 
as well as good convergent and discriminate validity (Robinson et al., 2014). The TLFB was 
administered at baseline, weekly during weeks 1-3 post-discharge, and at the 4 and 12-week 
follow-up visits. 
Coping Strategies Scale (CSS; Litt et al., 2008; Sugarman et al., 2010). Coping 
strategies were assessed using a modified version of the CSS. The CSS was originally adapted 
from the Processes of Change questionnaire (Prochaska et al., 1988) to assess alcohol-related 
coping strategies. Subsequent research modified this measure for use among pathological 
gamblers (Petry et al., 2007) and marijuana users (Litt et al., 2008). Most recently, Sugarman and 
colleagues (2010) adapted this measure to include 17 items that assess coping strategies for both 
alcohol and other drugs. Cronbach’s alpha for the 17 items was .82. Participants rated the 
frequency with which they employed specific coping strategies over the past week on a 5-point 
Likert scale (0 = never, 4 = all the time). Scores range from 0 to 68, with higher scores indicating 
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more coping strategies. The CSS was administered at baseline, discharge, weekly during weeks 
1-3 post-discharge, and at the 4 and 12-week follow-up visits. 
Brief Substance Craving Scale (BCBS; Somoza et al., 1995). Craving for primary drug 
of abuse was assessed using eight items from the BCBS. The BCBS measures the intensity, 
frequency, and length of cravings during the past 24 hours. Items are rated on a 0-4 Likert scale 
and summed to yield an overall measure of craving ranging from 0-12. The BSCS was 
administered at baseline, discharge, and the 4 and 12-week follow-up visits. 
Fagerstrom Test for Nicotine Dependence (FTND, Heatherton et al., 1991). The FTND 
is a widely used 6-item measure of nicotine dependence. The scores range from 0 to 10, with 
higher scores indicating greater nicotine dependence. The FTND was administered at baseline, 
discharge, and the 4 and 12-week follow-up visits.  
Center for Epidemiological Studies Depression Scale (CES-D; Radloff, 1977). The 
CES-D is a 20-item measure of depressive symptomatology. Respondents rate how often they 
have experienced a range of depressive symptoms over the past week on a 5-point scale (0 = 
rarely or none of the time and 4 = most or all of the time). Scores range from 0-60, with higher 
scores representing greater severity of depressive symptoms and scores 16 indicating probable 
depression. A recent review of the CES-D demonstrated sensitivity was 0.87 and specificity of 
0.70 (Vilagut et al., 2016). The CES-D was administered at baseline, discharge, weekly during 
weeks 1-3 post-discharge, and at the 4 and 12-week follow-up visits. 
Generalized Anxiety Disorder (GAD-7; Spitzer et al., 2006). Anxiety symptoms were 
assessed using with the GAD-7. The GAD-7 is a 7-item anxiety measure, which scores the 7 core 
symptoms of generalized anxiety disorder over the past two weeks on a 4-point scale (0 = not at 
all and 3 = nearly every day). The diagnostic validity of the GAD-7 has been well established, 
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with a criterion-standard study performed in 15 primary clinics in the United States 
demonstrating good consistency between GAD-7 diagnosis and those of independent mental 
health professionals (sensitivity, 89%; specificity, 82%) (Spitzer et al, 2006). A score of  10 
represents a probable diagnosis of Generalized Anxiety Disorder. The GAD-7 was administered 
at baseline, discharge, and the 4 and 12-week follow-up visits. 
Perceived Stress Scale (PSS; Cohen et al., 1983). The PSS is a 10-item measure of the 
degree to which situations in one’s life are appraised as stressful over the past month. Each item 
is rated on a 5-point scale (0 = never, 4 = almost always) and scores range from 0 to 40. 
Positively worded items are reverse scored and responses are summed, with higher scores 
indicating more perceived stress. Scores ranging from 0-13 are considered low stress, 14-26 are 
considered moderate stress, and 27-40 are considered high perceived stress. The PSS has 
demonstrated adequate internal reliability (Cohen & Williamson, 1988). The PSS was 
administered at baseline, discharge, and the 4 and 12-week follow-up visits. 
Interpersonal Support and Evaluation List-12 (ISEL-12; Cohen et al., 1985). The 
ISEL-12 is a 12-item measure of the perceived availability of current social support (Cohen et 
al., 1985). Items are rated on a 4-point scale (0 = definitely false, 4 = definitely true) and summed 
to yield an overall measure of social support. Scores range from 0 to 36, with higher scores 
indicating more perceived availability of social support. The measure also consists of three 
subscales comprised of four items each, including appraisal, belonging, and tangible (scores 
range 0-12). The ISEL-12 has demonstrated good convergent and divergent validity, as well as 
adequate test-retest and internal reliability (Dinenberg et al., 2014, Cohen et al., 1985; Merz et 
al., 2014). The ISEL-12 was administered at baseline, discharge, and the 4 and 12-week follow-
up visits. 
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Participant Tracking Form. Participants completed the Participant Tracking Form and 
provided their current address and phone number(s) (home, cell, work), as well as the names, 
addresses and phone number for at least 3 persons who generally know the participant’s 
whereabouts and can get a message to her. This information was used to locate participants to 
schedule follow-up visits following treatment and was completed at baseline to ensure 
participants would be able to be contacted in the event they discharged from treatment early. 
This tracking form has been used successfully by Dr. Svikis and colleagues to achieve >75% 
follow-up rates with SUD populations (Langhorst et al., 2012).  
Table 1 
Assessment Measures and Schedule 
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Randomization. Following baseline assessment, participants were randomly assigned to 
either the CBT4CBT (intervention) or TAU condition (control) using a computer-generated 
random numbers table. 
CBT4CBT condition. The CBT4CBT program consists of seven modules based on a 
NIDA-published CBT manual (Carroll, 1998) used in several previous RCTs across a range of 
substance-using populations (Carroll et al., 1994; Carroll et al., 2005; Carroll et al., 2006). As 
described by Carroll et al., 2008, “the modules cover the following core concepts: 1) 
understanding and changing patterns of substance use, 2) coping with craving, 3) refusing offers 
of drugs and alcohol, 4) problem-solving skills, 5) identifying and changing thoughts about drugs 
and alcohol, and 6) improving decision-making skills.” The first module provides instructions 
about the program’s use. Following completion of this introductory module, participants could 
complete the modules in the order they wanted and could access the modules as many times as 
they wished. 
As described by Carroll et al., 2008, the material in each module is presented by first 
introducing a key concept with a brief ‘movie’ to depict a particular situation associated with 
substance use, explaining the key skill covered in the module with graphics and voice-overs, and 
then replaying the movie to illustrate a different outcome when the characters apply the skills to 
the situation. Each module is followed by an interactive assessment and a short vignette to 
further explain the skills covered, how to apply them across settings, and demonstrations of 
practice assignments (e.g., ‘homework’). This overall format is intended to mirror the CBT 
manual’s therapist guidelines for structuring sessions (e.g., introduction of the concept, didactic 
instruction, practice via modeling and role-plays, assessment of the patient’s understanding, and 
homework). Further, this format offers the unique advantages of multimedia computer-assisted 
  
 
31 
instruction, including presentation of information in a range of media formats. Each module 
takes approximately 45 minutes to complete. A demonstration of the CBT4CBT program can be 
found here: http://www.cbt4cbt.com  
In addition to the standard care provided at RBHA-NC, women in the CBT4CBT 
condition had access the CBT4CBT program on a tablet in a private area on-site. They were 
scheduled for a minimum of two sessions/week over the 3.5 weeks post-randomization (see 
Figure 1 for example timeline). Sessions were scheduled at times that did not interfere with the 
treatment curriculum at RBHA-NC (e.g., groups). In session 1, the PI or RA guided participants 
through their initial use of the program and answered any questions. In sessions 2-7, staff were 
available to assist participants with program access and to answer any questions. Participants 
accessed the program through an ID/password system to protect confidentiality and allow 
monitoring of how often they access the modules. These seven sessions provided protected time 
to access the interventions, but the women were able to access the modules and complete 
homework as much as they wished. 
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Figure 1. Intervention Timeline 
 
Control condition. In the control condition, women participated in treatment as usual at 
RBHA-NC. Participants attended group and individual counseling sessions and engaged with the 
range of treatment services offered through the RBHA-NC treatment program. Participants in the 
control group completed all the same baseline and follow-up assessments as women in the 
CBT4CBT condition. 
Discharge assessment. At discharge, participants completed an in-person assessment in 
which many of the assessments completed at baseline were administered again, including, the 
CES-D, GAD-7, PSS, CSS, ISEL-12, BSCS, and FTND (see Table 1). In addition, participants 
completed an evaluation of their treatment experience (described below) and the Participant 
Tracking Form was reviewed to ensure there were no changes/additions to their contact 
information. The smartphone assessments were also piloted on the participant’s phone prior to 
discharge. RA/PI completed the discharge assessment and answered any questions about the 
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smartphone and study follow-up procedures. Participants received a $20 gift card following the 
assessment. In the event participants discharged from treatment early and were unable to 
complete their discharge assessment prior to leaving, the RA/PI called them and completed the 
assessment over the phone. If completed via phone, the participant was emailed their gift card, or 
it was provided in person at their 4-week follow-up visit. 
Treatment Satisfaction Scale. Participants completed a 10-item measure of treatment 
satisfaction (Carroll et al., 2008). They were asked to rate their level of agreement with 
satisfaction statements (e.g., “Overall, how satisfied are you with the treatment you received?”) 
on a 5-point scale. Participants in the CBT4CBT condition completed an additional 15 items 
specifically about their satisfaction with the CBT4CBT program. Participants rated their 
agreement with a range of statements about different aspects of the CBT4CBT program (e.g., 
“The computer program helped me think about my problems in a new way”). 
Post-Discharge Follow-Up Assessments 
Weeks 1, 2, and 3 post-discharge. Participants completed brief weekly assessments via 
their smartphones on days 7, 14, and 21 following discharge. Survey Monkey was used to collect 
the weekly smartphone assessments. This method was chosen due to its detailed privacy policy it 
provides, as well as the fact that it is HIPAA compliant. Survey Monkey allowed the assessments 
to be sent via text message, limiting any barriers to completing the post-discharge assessments. 
Only a subset of items from the baseline assessment battery were administered. In order 
to keep the assessment brief and encourage patient participation, each brief assessment (<10 
minutes) included a subset of questions from the primary and other central outcome measures, 
including substance use, coping skills, and mood. Using TLFB framework, participants reported 
on days of use over the past week. Participants received text message reminders to complete each 
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assessment weekly. The survey was password protected to ensure only study participants 
accessed the survey. If the survey was not completed within the first two hours of the text 
message, a reminder was sent. The weekly phone assessments helped maintain contact with the 
women post-discharge and served as a reminder for their 4-week follow-up assessment. 
Participants received a $10 gift card for each phone assessment ($30 total). Gift cards were 
provided via email or at the 4-week follow up visit.  
Note*: Participants were also provided with the option to have the RA/PI call them to complete 
their phone assessments verbally. This option was offered due to many participants not having 
texting capabilities on their phone and/or feeling more comfortable being called than having to 
navigate the web-based survey. This procedure change was made in an effort to maximize data 
collection and maintain contact with participants in the follow-up period. 
4 and 12-Week post-discharge assessments. The 4 and 12-week follow-up visits were 
in person visits at the Institute for Women’s Health. This location was chosen due to participants 
being unable to return to RBHA-NC following discharge from treatment. The visit took 
approximately 60 minutes to complete and were scheduled at discharge with smartphone 
reminder one week and one day prior to appointment. If participants did not show for their 
appointment they were called using the information provided on their Participant Tracking Form. 
Assessment included a subset of baseline measures (see Table 1), as well as the Treatment 
Services Review (described below). Urine drug screens and Breathalyzers were also 
administered at these visits in order to provide biological confirmation of self-report data. 
Participants received a $30 gift card for each assessment.  
Treatment Services Review (TSR; McLellan et al., 1992). The TSR was used to ask 
about any treatment services received over the past 28 days. The TSR asks about services 
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received across seven domains, including medical status, employment and support, drug use, 
alcohol use, legal status, family/social status, and psychiatric status. The TSR has demonstrated 
test-retest reliability, concurrent validity, and correspondence with independent measures of 
treatment provided (McLellan et al., 1992). The TSR was administered at the 4 and 12-week 
follow-up visits in order to gain an understanding of any treatment services received since being 
discharged from residential treatment. 
Urine Drug Screen. A 5-panel urine drug screen from a certified FDA approved supplier 
(drugstrips.com) was used to test for cocaine, amphetamines, marijuana (THC), opiates and 
phencyclidine at the 4 and 12-week follow-up visits.  
Breathalyzer. A Breathalyzer was also used to confirm recent self-reported alcohol use at 
the 4 and 12-week follow-up visits. 
Compensation. Participants received $20 each for baseline and discharge assessments, 
$10 for each phone check-in ($30 total) and $30 each for the 4 and 12-week follow-ups for a 
total of $130 in gift cards to local merchants (e.g., Target).  
Note*: In addition to physical gift cards, the study also started offering compensation via 
electronic gift cards in July 2019. This addition was made to facilitate payment for the phone 
assessments, as well as payment to participants who were unable to complete the 4 and 12-week 
follow-up visits in person. 
Outcome Measures 
 Any Relapse: Defined as any substance use (alcohol or other drugs) by self-report 
(smartphone or in person) and/or urine drug toxicology or Breathalyzer during 12-week follow-
up period. 
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 Relapse to Primary Drug of Choice: Any use by self-report and/or urine or 
Breathalyzer of relapse to the participant’s primary drug of choice during the 12-week follow-up 
period.  
Days of Use (Any): Number of days of any substance use in 12 weeks post-discharge. 
Days of Use (Primary): Number of days of use of primary drug of choice during 12-
week follow-up period. 
Time to Relapse: Number of days post discharge to first use of any substance.  
 Coping Strategies: Mean score across 17 items on the Coping Strategies Scale, with 
higher scores representing greater coping. 
Data Analysis Plan 
 Descriptive statistics were computed to examine participant characteristics. T-test and 
chi-square analyses were used to determine whether there were significant differences between 
the experimental and control conditions at baseline.  
Hypotheses 1. The primary hypothesis predicted that women in the CBT4CBT group 
would be less likely to relapse (Y/N) during the 12-week follow-up period than women in TAU.  
To test this hypothesis, relapse rates (yes/no over the 12-week follow-up period) were compared 
for the two groups using chi-square analyses. Analyses examined both relapse to any substance 
(regardless of drug class) and relapse to primary drug.  
Hypothesis 2. The second hypothesis predicted women in the CBT4CBT group would 
report fewer days of substance use compared to women in TAU during the 12-week follow-up 
period. To evaluate this hypothesis, days of substance use (both use of any substance and 
primary drug of choice) during the 12-week follow-up period were compared across the two 
groups using a two-sample t-test. In addition, analyses were repeated using a more conservative 
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Mann-Whitney U test to account for non-normality of the primary outcome variable. Standard 
effect sizes were also calculated to inform sample sizes needed for powering future studies. 
Finally, a Kaplan-Meier analysis was performed to compare the two groups with regards 
to time to relapse. Women who did not relapse were treated as censored observations, while 
those who did relapse were considered non-censored observations (observed failures). 
Missing data. Missing data were handled in several ways. First, intention to treat 
analyses were conducted to include all participants who enrolled in the study (N=61). Second, 
analyses were repeated on a subgroup of the intent-to-treat sample, excluding participants who 
dropped out of the study within one-week post-randomization (N = 55). Third, analyses were 
completed on “study completers”, defined as women who completed the study through at least 
the 4-week follow-up visit (N = 44). Participants missing all follow-up data were considered 
relapsed on day one (for both primary and any substance use) following discharge from 
residential treatment; all other data was carried forward from the last point of contact with the 
participant (e.g., discharge carried forward to 12-week follow-up). 
Hypothesis 3. The third hypothesis predicted that women in the CBT4CBT group would 
have higher coping scores over time compared to TAU and that higher coping scores would be 
associated with a lower risk of relapse. To test this hypothesis, we compared coping strategies 
(CSS) across the two groups at baseline, discharge, and 12-week follow-up using repeated 
measures analysis of variance (RMANOVA). These RMANOVA were performed using a mixed 
linear model. The model’s fit included one between-subjects factor (group: TAU, CBT4CBT), 
one within-subjects factor (time: baseline, discharge, 12-week follow-up), and the interaction 
between group and time. A significant groupxtime interaction would indicate that both factors 
were significant and differences would be evaluated using post-hoc comparisons. These post-hoc 
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tests were adjusted for multiple comparisons using a standard Bonferroni correction. In addition, 
exploratory analyses examined relationships between coping strategies and substance use 
variables across conditions using Pearson correlations. 
Exploratory analyses. Lastly, exploratory analyses were used to identify correlates of 
treatment outcomes. Baseline measures examined included: medication-based treatment for 
opioid use disorder (MOUD) (yes/no), stress management (PSS), social support (ISEL-12), 
psychiatric symptomatology (GAD-7, CES-D), craving (BSCS), as well as smoking status and 
nicotine dependence (FTND). Intervention variables included: number of CBT sessions 
completed, number of homework exercises completed, and time spent engaged in the 
intervention. Post-discharge variables included: engagement in outpatient treatment, and AA or 
NA attendance. Within and across group comparisons were made using chi-square analyses for 
categorical and t-tests for continuous measures. Pearson correlations were also conducted to 
analyze influence of variables on primary outcomes (e.g., days of substance use post-discharge). 
Results 
Flow of Participants through Study 
 A schematic diagram summarizing participant flow through the study from recruitment 
through the 12-week follow-up visit is shown in Figure 2. A total of n = 82 women were 
approached to participate in the study following their admission to residential treatment. Of 
those, 12 were ineligible and 7 women were not interested in participating. A total of n = 63 
provided informed consent, completed the baseline assessment, and were randomized to either 
the intervention (CBT4CBT; n = 34) or control (TAU; n = 29) conditions.  
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Figure 2. Flow chart of participants through study 
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Attrition from Study 
 As shown in Figure 2, n =6 women in the CBT4CBT condition discontinued study 
participation within one-week post-randomization. Of these women, n = 4 withdrew from study 
participation while in treatment. One had completed two CBT4CBT modules, two had completed 
one module, and one withdrew prior to starting the CBT4CBT intervention. Reasons for 
discontinuing study participation included lack of time and/or current stressors (n = 3) and 
dissatisfaction with lack of compensation for completing each CBT4CBT session (n =1). 
Further, a total of n = 2 women left treatment against medical advice (AMA), one was 
programmatically discharged for medical reasons and one elected to leave treatment early. The 
discharge assessment was completed by n = 24 women in each of the two treatment conditions 
(total N = 48). If women did not complete the discharge assessment prior to leaving treatment, 
they continued to be followed and invited to complete the follow-up assessments. 
 Rates of completion of weekly phone assessments at 1, 2, and 3 weeks post discharge 
ranged from n = 31 (week 1) to n = 33 (week 2) and finally n = 38 (week 3). Four participants 
were lost to follow-up for the entire 12-week follow-up period due to either incarceration (n = 3) 
or death (one participant passed away due to medical reasons unrelated to treatment 
participation). Research staff followed up with local jails regarding incarcerated participants, two 
participants were incarcerated for new drug-related charges and were considered relapsed in the 
follow-up dataset. One participant was incarcerated for reasons unrelated to substance use and 
was excluded from analyses, as was the participant who passed away shortly following discharge 
from residential treatment. Completion rates for study follow-up visits across treatment 
conditions are summarized in Table 2; there were no significant differences between study 
groups (all p > 0.05).  
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Table 2 
 
Study Visit Completion Rates in CBT4CBT and TAU Conditions 
 
 Baseline Discharge 1 week 2 weeks 3 weeks 4 weeks 12-week 
CBT4CBT 
(n = 34) 
% or M (SD) 
 
100% 
(34) 
 
 
70.6% 
(24) 
 
41.2% 
(14) 
47.1% 
(16) 
50.0% 
(17) 
67.6% 
(23) 
55.9% 
(19) 
TAU 
(n = 29) 
% or M (SD) 
100% 
(29) 
 
82.8% 
(24) 
 
58.6% 
(17) 
58.6% 
(17) 
58.6% 
(17) 
72.4% 
(21) 
65.5% 
(19) 
 
Demographics 
 Table 3 summarizes demographic characteristics for the entire sample and separately for 
participants randomized to the CBT4CBT and TAU groups. Overall, women were in their early 
40’s (M = 41.2, SD = 12.1, range 18-65 years) and the majority identified their race as 
Black/African American (79.4%). Nearly half reported at least a high school education or 
obtained their GED (49.2%), and the majority were single/never married (73%). While more 
than four-fifths of the sample reported having one or more children (87.3%), nearly two-thirds 
(64.5%) of those with at least one child had no children currently living with them. There were 
no significant group differences across participant characteristics (all p > 0.05).  
Table 3 
 
Participant Characteristics 
 
 CBT4CBT 
(n = 34) 
% or M (SD) 
TAU 
(n = 29) 
% or M (SD) 
Total 
(n = 63) 
% or M (SD) 
 
p value 
Age (years) 39.8 (11.3) 42.8 (12.9) 41.2 (12.1) 0.31 
Race 
     Black/African American 
     Caucasian 
 
76.5% (26) 
17.6% (6) 
 
82.8% (24) 
10.3% (3) 
 
79.4% (50) 
14.3% (9) 
 
0.71 
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     Other 5.9% (2) 6.9% (2) 6.3% (4) 
Education  
     Less than high school 
     Grade 12 or GED 
     Some college and beyond 
 
29.4% (10) 
50.0% (17) 
20.6% (7) 
 
13.8% (4) 
48.3% (14) 
37.9% (11) 
 
22.2% (14) 
49.2% (31) 
28.6% (18) 
 
0.19 
Marital Status 
      Single/Never Married 
      Married/In a relationship 
      Divorced/Separated/Widowed 
 
79.4% (27) 
14.7% (5) 
5.9% (2) 
 
65.5% (19) 
6.9% (2) 
27.6% (8) 
 
73.0% (46) 
11.1% (7) 
15.9% (10) 
 
0.06 
Employment 
     Full Time 
     Part Time 
     Unemployed 
     On disability 
     Homemaker/Mom 
 
35.3% (12) 
2.9% (1) 
50.0% (17) 
2.9% (1) 
8.8% (3) 
 
20.7% (6) 
17.2% (5) 
51.7% (15) 
3.4% (1) 
6.9% (2) 
 
28.6% (18) 
9.5% (6) 
50.8% (32) 
3.2% (2) 
7.9% (5) 
 
0.33 
Note. CBT4CBT = Intervention Condition; TAU = Treatment as usual; Total = Total Sample 
 
Descriptive Analyses 
 Psychosocial History. Psychosocial variables from the Addiction Severity Index (ASI) 
for the CBT4CBT and TAU groups are summarized in Table 4. Over three-fourths (85.7%) of 
participants entered residential treatment from a controlled environment, with over two-thirds 
(71.4%) coming from another alcohol/drug treatment facility (e.g., detox, another residential 
treatment facility). Over half of the women (52.4%) endorsed having a chronic medical illness 
and an average of 3.2 (SD = 4.4, range 0-21) medical hospitalizations throughout their lifetime. 
Over half of women (58.7%) reported past history of treatment for drug use. In that group, the 
mean number of previous treatment episodes was 3.4 (SD = 2.5, range 2-16). Over one-fourth of 
participants (27%) indicated their admission to residential treatment was prompted or suggested 
by the criminal justice system, and two-thirds (66.7%) of women reported one or more 
convictions for a criminal offense. In the psychiatric domain, over half of women reported a 
history of inpatient or outpatient care (57.1% and 54.0%, respectively) and over three-fourths of 
women (81.0%) had been prescribed a medication for a mental health problem. Over half of 
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participants reported a history of physical and/or sexual abuse (55.6% and 50.8%, respectively). 
There were no significant group differences in psychosocial variables from the ASI at baseline 
(all p > 0.05). 
Table 4 
 
Psychosocial Variables from the Addiction Severity Index (ASI) 
 
 CBT4CBT 
(n = 34) 
% or M 
(SD) 
TAU 
(n = 29) 
% or M 
(SD) 
Total 
(n = 63) 
% or M 
(SD) 
Any controlled environment (30 days prior to tx) 
          Jail 
          Alcohol/drug treatment 
          Medical treatment 
94.1% (32) 
14.7% (5) 
73.5% (25) 
5.9% (2) 
75.9% (22) 
6.9% (2) 
69.0% (20) 
0.0% (0) 
85.7% (54) 
11.1% (7) 
71.4% (45) 
3.2% (2) 
Medical 
          Hospitalizations (lifetime) 
          Chronic medical illness 
          Medical disability 
 
3.0 (4.5) 
47.1% (16) 
2.9% (1) 
 
3.4 (4.3) 
58.6% (17) 
0.0% (0) 
 
3.2 (4.4) 
52.4% (33) 
1.6% (1) 
History of SUD treatment (lifetime) 
         Any previous drug treatment (% yes) 
         No. of tx episodes (of individuals with  1) 
 
55.9% (19) 
3.2 (1.6) 
 
62.1% (18) 
3.6 (3.2) 
 
58.7% (37) 
3.4 (2.5) 
Legal 
          Admission suggested by criminal justice system 
          Criminal convictions (Y/N) 
          No. of convictions (of individuals with  1) 
 
20.6% (7) 
70.6% (24) 
4.8 (5.5) 
 
34.5% (10) 
62.1% (18) 
2.7 (1.5) 
 
27.0% (17) 
66.7% (42) 
3.9 (4.4) 
Psychiatric History 
         Inpatient care 
         Outpatient care 
         Rx for psychological problem (lifetime) 
 
67.6% (23) 
50.0% (17) 
85.3% (29) 
 
44.8% (13) 
58.6% (17) 
75.9% (22) 
 
57.1% (36) 
54.0% (34) 
81.0% (51) 
Abuse History (Lifetime) 
        Physical Abuse 
        Sexual Abuse 
 
58.8% (20) 
55.9% (19) 
 
51.7% (15) 
44.8% (13) 
 
55.6% (35) 
50.8% (32) 
 
Alcohol and Drug Use (lifetime). Participants reported drinking regularly (three or more 
days/week) for an average of 10.4 years (SD = 11.7) (lifetime) and drinking three or more 
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drinks/occasion nearly all of those years (M = 10.1, SD = 11.4). Nearly two-thirds (60.3%) of the 
sample reported a history of regular heroin use, with 4.8 average years (SD = 6.4) of use. Over 
half (57.9%) of these women reported using heroin intravenously and over one-third (42.1%) 
reported nasal use. Nearly two-thirds of women (30.2%) reported use of other opiates, with 1.9 
average years (SD = 4.5) of use. Nearly three-fourths (74.6%) of women reported a history of 
cocaine use; most women (88.2%) reported smoking cocaine, with some women reporting 
intravenous (7.8%) and nasal use (7.8%). Nearly two-thirds (65.1%) of women reported regular 
use of cannabis, with an average of 9.0 years (SD = 9.6) of use. Most participants (81.0%) 
reported concurrent regular use of two or more substances, with an average of 9.9 years (SD = 
9.3) of regular use.  
Substance Use (past 28 days) Prior to Treatment Admission. Because the majority of 
the sample entered treatment from a controlled environment (e.g., inpatient alcohol or drug 
treatment, medical hospitalization, jail), substance use was examined separately based on how 
many days participants had access to alcohol and other drugs. Over one-third (38.1%) of the 
sample was in a controlled environment for the entirety of the 28 days prior to treatment entry 
and reported no drug use within this timeframe. Nearly half (47.6%) of the sample spent 
approximately one week (M = 6.1 days, SD = 2.5) in a controlled environment prior to their 
admission to RBHA-NC, with most (80%) of these women coming to residential treatment after 
completing 5-7 days of detox. Among these women, they reported an average of 21.1 days of 
substance use, with use of their primary drug of choice nearly all of these days (M = 21.0, SD = 
4.1). Only 9 women (14.2%) were not in any type of controlled environment prior to treatment 
entry.  These women reported drug use an average of 14.1 days (SD = 12.5) in the 28 days prior 
to baseline, with 10.8 days (SD = 11.1) of primary drug use.  
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DSM-5 Substance Use Disorder Diagnoses (current). Current (past 12 months) SUD 
diagnoses are summarized in Table 5. Cocaine and opioids were the most frequent diagnoses, 
with nearly three-fourths (73.0%) of the sample meeting criteria for severe cocaine use disorder 
and 61.9% meeting criteria for severe opioid use disorder. Over one-third (38.1%) of the sample 
met criteria for severe alcohol use disorder. Sedatives and stimulants were less common, with 
only 1.6% of the sample meeting diagnostic criteria for these disorders. Polysubstance use was 
common among study participants, with two-thirds (66.7%) of the sample meeting DSM-5 
criteria for more than one SUD. There were no significant differences in current SUD diagnoses 
at baseline for the two treatment conditions (all p > 0.05).  
Table 5 
 
DSM-5 Substance Use Disorders Diagnoses (current) for Study Participants 
 
 CBT4CBT 
(n = 34) 
% or M (SD) 
TAU 
(n = 29) 
% or M (SD) 
Total 
(n = 63) 
% or M (SD) 
Alcohol Use Disorder, mild 0.0% (0) 3.4% (1) 1.6% (1) 
Alcohol Use Disorder, moderate 0.0% (0) 3.4% (1) 1.6% (1) 
Alcohol Use Disorder, severe 35.3% (12) 41.4% (12) 38.1% (24) 
Cocaine Use Disorder, severe 76.5% (26) 69.0% (20) 73.0% (46) 
Opioid Use Disorder, severe 64.7% (22) 58.6% (17) 61.9% (39) 
Sedative Use Disorder, severe 2.9% (1) 0.0% (0) 1.6% (1) 
Stimulant Use Disorder, severe 2.9% (1) 0.0% (0) 1.6% (1) 
Met criteria for 2 or more DSM-5 
SUD (current) 
70.6% (24) 62.1% (18) 66.7% (42) 
 
Primary Problems at Baseline. Primary substance use problems, identified by 
participant self-report, are summarized in Table 6. Opioids and cocaine use were among the most 
frequently identified (61.9% and 73.0%, respectively), with nearly half (47.6%) of the sample 
reporting both of these substances as their primary problem. Opioid use was predominantly 
  
 
46 
heroin use, with only 3.2% of the sample identifying prescription opioids as their primary 
problem. Over one-third of the sample reported alcohol use as their primary problem. Stimulants 
and sedatives were endorsed at the lowest rates across groups (1.6% and 1.6%, respectively). 
There were no group differences in primary problems (all p > 0.05). 
Table 6 
 
Primary Problems at Baseline for Study Participants 
 
 CBT4CBT 
(n = 34) 
% or M (SD) 
TAU 
(n = 29) 
% or M (SD) 
Total 
(n = 63) 
% or M (SD) 
Opioids 
      Heroin 
      Prescription Opioids 
64.7% (22) 
61.8% (21) 
3.4% (1) 
58.6% (17) 
55.2% (16) 
2.9% (1) 
61.9% (39) 
58.7% (37) 
3.2% (2) 
Cocaine 76.5% (26) 69.0% (20) 73.0% (46) 
Alcohol 35.3% (12) 44.8% (13) 39.7% (25) 
Stimulants 2.9% (1) 0.0% (0) 1.6% (1) 
Sedatives 2.9% (1) 0.0% (0) 1.6% (1) 
 
Smoking and Nicotine Dependence. Smoking status at baseline and nicotine 
dependence, as measured by the Fagerstrom Test for Nicotine Dependence (FTND), is 
summarized in Table 7. Most study participants (88.9%) reported currently smoking, with a 
mean of 5.3 (SD = 2.3) on the FTND, indicating a moderate level of nicotine dependence. There 
were no significant differences in baseline smoking status or FTND scores across study 
conditions (all p > 0.05). 
Table 7 
 
Smoking Status and Nicotine Dependence 
 
 CBT4CBT 
(n = 34) 
% or M (SD) 
TAU 
(n = 29) 
% or M (SD) 
Total 
(n = 63) 
% or M (SD) 
Current Smoker (% Yes) 82.4% (28) 96.6% (28) 88.9% (56) 
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Nicotine Dependence (among smokers) 5.7 (2.4) 4.9 (2.1) 5.3(2.3) 
 
Craving and Coping Strategies at Baseline. Craving for primary substance of use and 
coping strategies at baseline across the two groups are summarized in Table 8. Participants 
reported high baseline levels of craving, as measured by the Brief Substance Craving Scale, with 
a mean score of 10.7 out of 12. Participants reported low levels of baseline coping, as measured 
by the Coping Strategies Scale, with a mean score of 13.4 (SD = 16.9) out of 68. There were no 
differences between the two conditions in levels of coping or craving at baseline (all p >0.05). 
Table 8 
 
Craving (primary substance) and Coping Strategies at Baseline 
 
 CBT4CBT 
(n = 34) 
% or M (SD) 
TAU 
(n = 29) 
% or M (SD) 
Total 
(n = 63) 
% or M (SD) 
Craving (BSCS; primary substance) 11.1 (1.2) 10.21 (2.1) 10.7 (1.7) 
Coping Strategies (CSS score) 10.4 (16.5) 17.0 (17.0) 13.4 (16.9) 
 
Psychosocial Variables at Baseline. Baseline psychosocial variables are summarized in 
Table 9. Nearly three-fourths (73%) of the women obtained clinically elevated scores on the 
CES-D at baseline, with a mean score of 28.1 (SD = 15.3). Over half (55.6%) of the participants 
reported clinically elevated levels of anxiety on the GAD-7 at baseline, with a mean score of 
11.1 (SD = 7.0). The mean score on the Perceived Stress Scale at baseline was 23.8 (SD = 8.0), 
indicating moderate levels of perceived stress. Regarding social support, the women had a mean 
score of 23.8 (10.3) on the Interpersonal Support Evaluation List at baseline, with scores ranging 
from 2 to 36 and higher scores indicating greater levels of social support. There were no 
differences between the two conditions on psychosocial variables at baseline (all p > 0.05). 
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Table 9 
 
Psychosocial Variables at Baseline 
 
 CBT4CBT 
(n = 34) 
% or M (SD) 
TAU 
(n = 29) 
% or M (SD) 
Total 
(n = 63) 
% or M (SD) 
Depression (CES-D score) 26.1 (16.0) 30.4 (14.3) 28.1 (15.3) 
CES-D Cutoff  16 67.6% (23) 79.3% (23) 73.0% (46) 
Anxiety (GAD-7 score) 10.9 (7.4) 11.2 (6.6) 11.1 (7.0) 
GAD-7 Cutoff  10 58.8% (20) 51.7% (15) 55.6% (35) 
Perceived Stress (PSS score) 23.4 (8.9) 24.3 (6.9) 23.8 (8.0) 
Social Support (ISEL Score) 25.6 (9.6) 21.8 (10.9) 23.8 (10.3) 
 
Treatment Adherence  
Residential Treatment. Women in the TAU condition completed a mean of 50.9 days 
(SD = 21.8, range 20-111), with a median length of stay of 46 days. Women in the CBT4CBT 
group completed a mean of 42.8 days (SD = 20.25; range 3-81), with a median length of 43 days. 
There was no significant difference in length of treatment between the TAU and CBT4CBT 
groups (p > 0.05). None of the participants in the TAU condition left treatment AMA or 
withdrew from study participation. In the CBT4CBT group, two women left treatment AMA 
within one-week post randomization, one was programmatically discharged for medical reasons 
and one elected to leave treatment early. Four women in the CBT4CBT condition withdrew from 
study participation but continued in residential treatment. One participant in the CBT4CBT 
condition eloped from treatment against medical advice (AMA); the research team continued to 
contact her regarding study participation but was unable to reach her for follow-up. 
CBT4CBT Program. CBT4CBT intervention dose (# sessions) information is 
summarized in Table 10. Of the 34 women randomized to the CBT4CBT condition, 29 
completed at least 1 module of the CBT4CBT program. Of the women who did not complete any 
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modules, two left treatment AMA within a few days of their admission, one was transferred to 
another treatment facility within a few days of her admission, one withdrew from the study prior 
to completing her first module, and one elected to not complete any modules throughout her 
residential care. Of the participants who initiated the CBT4CBT program, they completed a 
mean of 5 modules (SD = 2) and spent an average of 31 minutes (SD = 13.2; range 10-67 
minutes) completing each module. Participants tended to complete the modules in the 
recommended order, with everyone completing module 1 (e.g., Recognize the Triggers), 
approximately three-fourths completed each of the modules 2-6, and just over half (58.6%) 
completed module 7 (e.g., Stay Safe). Most of the women (75.9%) completed at least one of the 
weekly homework assignments, with a mean of 4 assignments completed (SD = 3). Notably, 
among the women who initiated the CBT4CBT program, over two-thirds (72.4%) completed six 
or more of the modules and over half (55.2%) of the women completed all seven modules. 
Further, over one-third (34.5%) of the women completed all seven of the weekly homework 
assignments. Monitoring of access to the CBT4CBT program indicated that only one woman 
accessed the program outside of the protected time provided by the research team while in 
residential treatment and that none of the participants accessed the program following discharge 
from residential treatment. 
Table 10 
 
Treatment Adherence to the CBT4CBT Program 
 
 Participants who Initiated 
CBT4CBT Program 
(n = 29) 
% or M (SD) 
Number of CBT4CBT Modules Completed (range 1-7) 
       One 
       Two 
5 (2) 
10.3% (3) 
10.3% (3) 
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       Three 
       Four 
       Five 
       Six 
       Seven 
6.9% (2) 
0.0% (0) 
0.0% (0) 
17.2% (5) 
55.2% (16) 
Mean Time per Module (minutes) 31 (13.2) 
Modules Completed (in recommended order): 
       Recognize the Triggers 
       Deal with Cravings 
       Stand Up for Yourself 
       Stop and Think 
       Plan Don’t Panic 
       Go Against the Flow 
       Stay Safe 
 
100% (29) 
89.6% (26) 
72.4% (21) 
72.4% (21) 
75.9% (22) 
72.4% (21) 
58.6% (17) 
Homework Assignments Completed (range 0-7) 
       Zero 
       One 
       Two 
       Three 
       Four 
       Five 
       Six 
       Seven 
4 (3) 
24.1% (7) 
13.8% (4) 
6.9% (2) 
0.0% (0) 
3.4% (1) 
10.3% (3) 
6.9% (2) 
34.5% (10) 
 
Hypothesis One 
 The study hypothesized that women in the CBT4CBT group would be less likely 
to relapse (Y/N) during the 12-week follow-up period than women in TAU. As shown in Table 
11, for any relapse (regardless of drug class), the two groups did not significantly differ, 43.5% 
in the CBT4CBT condition compared to 47.6% in TAU, 2(1, N=44) = .08, p = 0.78. For relapse 
to primary substance, 30.4% of women in the CBT4CBT condition relapsed compared to 47.6% 
in TAU, 2(1, N=44) = 1.4, p = 0.24. This same pattern of results was seen in the intention to 
treat samples.  
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Hypothesis Two 
The study also hypothesized that women in the CBT4CBT group would report fewer 
days of substance use compared to women in TAU during the 12-week follow-up period. As 
shown in Table 12, women in the TAU condition reported nearly twice as many days of any 
substance use (M = 9.8, SD = 16.3) compared to women in the CBT4CBT condition (M = 5.7, 
SD = 14.2); however, this difference was not statistically significant, t (42) = 0.88, p = 0.39. 
Regarding days of use of primary substance, women in the TAU condition reported nearly three 
times more days of use (M = 9.2, SD = 16.5) compared to women in the CBT4CBT condition (M 
= 3.4, SD = 7.7); this difference also did not reach the level of significance t (27.8) = 1.46, p = 
0.16. This same pattern of results was seen in the intention to treat analyses.  
Table 11 
 
Relapse Rates and Days of Substance Use 12 Weeks Post-Discharge 
 
 CBT4CBT 
% or M (SD) 
TAU 
% or M (SD) 
p value 
Study Completers (n=44) (n = 23) (n = 21)  
% Relapsed (Any substance) 43.5% (10) 47.6% (10) 0.78 
% Relapsed (Primary substance) 30.4% (7) 47.6% (10) 0.24 
Days of substance use (Any substance) 5.7 (14.2) 9.8 (16.3) 0.39 
Days of substance use (primary) 3.4 (7.7) 9.2 (16.5) 0.16 
Intention to Treat Sample (excluding dropouts 
within one-week post-randomization) (n=55) 
(n = 27) (n = 28)  
% Relapsed (Any substance) 51.9% (14) 60.7% (17) 0.51 
% Relapsed (Primary substance) 40.7% (11) 60.7% (17) 0.14 
Days of substance use (Any substance) 17.3 (31.2) 28.3 (35.6) 0.23 
Days of substance use (primary) 15.4 (30.0) 27.9 (35.9) 0.17 
Intention to Treat Sample (n=61) (n = 33) (n = 28)  
% Relapsed (Any substance) 60.6% (20) 60.7% (17) 0.99 
% Relapsed (Primary substance) 51.5% (17) 60.7% (17) 0.47 
Days of substance use (Any substance) 29.5 (38.4) 28.3 (35.6) 0.91 
Days of substance use (primary) 27.8 (38.1) 27.9 (35.9) 0.99 
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Time to Relapse (Any Substance). A Kaplan-Meier analysis was performed to compare 
the two groups with regards to time to relapse. As shown in Figure 3, Panel A, the CBT4CBT 
condition had lower relapse rates to any substance over time; however, this difference did not 
reach statistical significance, Log Rank (Mantel-Cox) = 0.14; df 1; p = 0.71. The mean survival 
time for the CBT4CBT group was 57.4 days (SD = 6.8) compared to 51.8 days (SD = 7.5) for 
women in the TAU condition. Nearly all participants who relapsed to any substance did so in the 
first four weeks post-discharge from residential treatment. The mean time to relapse across the 
sample was 19.7 days (SD = 15.7) with women in the TAU condition reporting a shorter time to 
relapse (M = 16.4, SD = 9.4) compared to women in the CBT4CBT condition (M = 22.9, SD = 
20.2). This pattern of results was consistent across the intention to treat analyses (Figure 3, Panel 
B).  
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Figure 3. Survival analysis of relapse to any substance 
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Time to Relapse (Primary Substance). Survival curves for time to relapse to primary 
substance of use across the two treatment conditions are shown in Figure 4, Panel A. Consistent 
with relapse to any substance, the CBT4CBT condition had lower relapse rates over time. While 
this difference did not reach statistical significance, Log Rank (Mantel-Cox) = 1.46; df 1; p = 
0.23), the mean survival time for the CBT4CBT group was 67.0 days (SD = 6.1) compared to 
53.2 days (SD = 7.1) for women in the TAU condition. The pattern of results showed that all of 
the women who relapsed to their primary substance of use in the TAU condition, did so within 
the first four weeks post-discharge, while women in the CBT4CBT group showed a more 
gradual relapse rate over time. The mean time to relapse across the sample was 23.1 days (SD = 
18.3) with women in the TAU condition reporting a shorter time to relapse (M = 19.4, SD = 8.9) 
compared to women in the CBT4CBT condition (M = 28.3, SD = 26.8). Further, among study 
completers, relapse rates to primary substance at the 4-week follow-up visit approached 
statistical significance, with 42.9% of women in the TAU condition compared to 17.4% of 
women in the CBT4CBT group, 2(1, N=44) = 3.42, p = 0.06. This pattern of results was 
consistent across the intention to treat analyses (Figure 4, Panel B). All other substance use 
outcome data at the 4-week follow-up visit was consistent with the pattern of results seen at the 
12-week follow-up. 
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Figure 4. Survival analysis of relapse to primary substance 
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Medication-Based Treatment for OUD and Primary Outcomes 
Given that over half (54.0%) of the sample was prescribed medications for OUD 
(MOUD), analyses were also completed to examine treatment outcomes separately within 
women receiving MOUD and those not receiving MOUD. While the groups did not significantly 
differ across these analyses, treatment outcomes in women not on MOUD demonstrated a larger 
difference across conditions than that seen in the full sample.  As shown in Table 12, nearly 
twice (44.4%) as many women in the TAU condition relapsed to any substance compared to 
women in the CBT4CBT condition (25.0%), 2(1, N=21) = 0.88, p = 0.35. For relapse to primary 
substance, nearly three times (44.4%) as many women in the TAU condition relapsed compared 
to women in the CBT4CBT group (16.7%), 2(1, N=21) = 1.94, p = 0.16. Regarding days of 
substance use, women in the TAU condition reported over seven times more days of use of any 
substance, t (8.6) = 1.42, p = 0.19, and over eight times more days of use of their primary 
substance compared to women in the CBT4CBT condition t (8.6) = 1.39, p = 0.20. Figure 5 
illustrates the differences in treatment outcomes among women receiving MOUD and those not 
receiving MOUD for both relapse to primary substance (Panel A) and days of primary substance 
use (Panel B). This same pattern of results was consistent across the intention to treat analyses. 
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Table 12 
 
Treatment Outcomes in Women Not Receiving MOUD 
 
 CBT4CBT 
% or M (SD) 
TAU 
% or M (SD) 
p value 
Study Completers (n=21) (n = 12) (n = 9)  
% Relapsed (Any substance) 25.0% (3) 44.4% (4) 0.35 
% Relapse (Primary substance) 16.7% (2) 44.4% (4) 0.16 
Days of substance use (Any substance) 1.2 (3.4) 8.8 (15.8) 0.19 
Days of substance use (primary) 1.1 (3.5) 8.6 (15.9) 0.20 
Intention to Treat Sample (excluding dropouts 
within one-week post-randomization) (n=27) 
(n = 14) (n = 13)  
% Relapsed (Any substance) 35.7% (5) 61.5% (8) 0.18 
% Relapse (Primary substance) 28.6% (4) 61.5% (8) 0.09 
Days of substance use (Any substance) 13.0 (30.2) 31.9 (38.4) 0.17 
Days of substance use (primary) 12.9 (30.3) 31.8 (38.4) 0.17 
Intention to Treat Sample (n=28) (n = 15) (n = 13)  
% Relapsed (Any substance) 40.0% (6) 61.5% (8) 0.26 
% Relapse (Primary substance) 33.3% (5) 61.5% (8) 0.13 
Days of substance use (Any substance) 17.7 (34.4) 31.9 (38.4) 0.31 
Days of substance use (primary) 17.7 (34.5) 31.8 (38.5) 0.32 
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Figure 5. Primary outcomes in MOUD and no-MOUD groups among study completers (N=44) 
Sample: N=23 MOUD (12 TAU, 11 CBT4CBT); N=21 No-MOUD (9 TAU, 12 CBT4CBT) 
 
Effect Size Estimation 
 Primary Treatment Outcome (Days of Use). Effect size estimation was accomplished 
using days of substance use in the follow-up period, looking at both days of any substance use 
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44) and intention to treat sample (excluding dropouts <1 week post-randomization; n = 55). The 
means and standard deviations for the days of substance use in the follow-up period yielded 
small to moderate effect sizes for both any substance use (range 0.27–0.32) and days of primary 
substance use (range 0.38–0.48) in the 12-week follow-up period.  A power analysis was 
performed using these estimated effect sizes to determine the sample size required for a larger 
clinical trial. It is estimated that a future RCT will need 70-110 participants per group for 80% 
power to detect an effect for days of primary substance use in the follow-up period. For any 
substance use (regardless of drug class), a future study would need 155-217 participants per 
group. 
 Primary Outcomes in Women Not Receiving MOUD. Effect size estimation was also 
completed looking at women not receiving MOUD. Within this sample, means and standard 
deviations for days of substance use in the follow-up period yielded moderate to large effect 
sizes for both any substance use (range 0.55–0.79) and days of primary substance use (range 
0.55–0.77). A power analysis was performed using these estimated effect sizes to determine the 
sample size required for a larger clinical trial conducted in women not currently receiving 
MOUD. It is estimated that a future RCT will need 27-53 participants per group for 80% power 
to detect an effect for days of primary substance use in the follow-up period. For any substance 
use (regardless of drug class), a future study would need 28-53 participants per group. 
Hypothesis Three 
Lastly, the study hypothesized that women in the CBT4CBT group would have higher 
coping scores over time compared to women in the TAU condition. Figure 6 shows the mean 
coping strategy scores as measured by the CSS at baseline, discharge, and the 12-week follow-up 
visit for each condition.  Mauchly’s Test of Sphericity indicated that the sphericity had been 
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violated, 2(2) = 30.27, p < .001; therefore, a Greenhouse-Geisser correction was used and 
indicated a significant effect of time on coping strategy scores, F (1.43, 84.1) = 121.1, p < .001. 
However, no significant condition x time interaction was observed, F (1.43, 84.1) = 1.18, p = 
0.30. As shown in Figure 6, the trend of coping scores over time was quadratic in nature, with 
low scores at baseline (M = 13.6, SD = 2.2), high coping scores at the time of discharge (M = 
54.6, SD = 2.9), and then slightly decreased at the 12-week follow-up visit (M = 50.1, SD = 3.0). 
This pattern of results was consistent across treatment conditions. 
 
Figure 6. Coping strategies at baseline, discharge and 12-week follow-up (n=61) 
We also hypothesized higher coping scores would be associated with a lower risk for 
relapse. Table 13 shows the correlation between substance use and coping scores across the 
treatment conditions. Using a one-way Pearson correlation test, a significant moderate negative 
correlation was found between coping scores and days of substance use in the 12-week follow-up 
period for both any (r = -0.68, p < 0.001) and primary (r = -0.65, p < 0.001) substance use. 
Further, when analyzed by condition, this relationship was found to be stronger for women in the 
CBT4CBT group for both any (r = -0.86, p < 0.001) and primary (r = -0.84, p < 0.001) substance 
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use compared to women in the TAU condition (r = -0.57, p < 0.01). This pattern of results was 
consistent across the intention to treat samples. 
Table 13 
 
Correlations of Substance Use Outcomes with Coping Strategies Scores 
 
 CBT4CBT 
CSS Score 
TAU 
CSS Score 
Total Sample  
CSS Score 
Study Completers (n=44)    
Days of substance use (Any substance) -0.86** -0.57* -0.68** 
Days of substance use (primary) -0.84** -0.57* -0.65** 
Intention to Treat Sample (excluding dropouts 
within one-week post-randomization) (n=55) 
   
Days of substance use (Any substance) -0.67** -0.50* -0.58** 
Days of substance use (primary) -0.61** -0.50* -0.56** 
Intention to Treat Sample (n=61)    
Days of substance use (Any substance) -0.69** -0.50* -0.61** 
Days of substance use (primary) -0.66** -0.50* -0.60** 
* p < 0.01, ** p < 0.001 
Exploratory Analyses 
 Exploratory analyses examined correlates of treatment outcomes. Analyzed variables 
included smoking, craving, depression, anxiety, stress, and social support. Engagement in 
treatment services following discharge was also examined and how this may influence risk for 
relapse. To minimize missing data, all Repeated Measures ANOVA analyses were completed on 
the full intention to treat sample, with any missing data replaced by carrying forward each 
participant’s previous score (e.g., baseline value or discharge value).  
Engagement in CBT4CBT Program and Primary Treatment Outcomes. The 
influence of engagement in the CBT4CBT program on treatment outcomes was also examined. 
For participants randomized to the CBT4CBT condition, the number of CBT4CBT modules 
completed had a significant negative correlation with days of any substance use in the 12-week 
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follow-up period (r = -0.41, p = 0.03). This correlation was also seen in intent-to-treat analyses 
(range -0.30 – -0.59, p < 0.05). There was also a negative correlation between CBT4CBT 
modules completed and days of primary substance use. While this relationship did not reach 
statistical significance among study completers (r = -0.14, p = 0.27), it was significant in the 
intent-to-treat analyses (r = -0.53, p = 0.001). 
Smoking. Smoking rates at the 12-week follow-up visit among women who reported 
smoking at baseline are summarized in Table 14. Nearly all of the women in the TAU condition 
resumed smoking by the 12-week follow-up visit (90.5%) compared to 80.0% of women in the 
CBTCBT condition. This pattern was consistent across the intention to treat analyses; however, 
the difference did not reach statistical significance (all p > 0.05). 
Table 14 
 
Smoking Rates Post-Discharge Among Baseline Smokers 
 
 
CBT4CBT 
% or M (SD) 
TAU 
% or M (SD) P value 
Study Completers (n=40) (n = 20) (n = 20)  
Current Smoker (% Yes) 80.0% (16) 95.0% (19) 0.15 
Intention to Treat Sample (excluding dropouts 
within one-week post-randomization) (n=50) 
 
(n = 23) (n = 27)  
Current Smoker (% Yes) 82.6% (19) 96.3% (26) 0.11 
Intention to Treat Sample (n=54) (n = 27) (n = 27)  
Current Smoker (% Yes) 85.2% (23) 96.3% (26) 0.16 
 
Nicotine Dependence. Levels of nicotine dependence were also examined over time. 
Figure 7 shows levels of nicotine dependence at baseline, discharge and the 12-week follow-up 
visit among women who reported smoking at treatment entry. Mauchly’s Test of Sphericity 
indicated that the sphericity had been violated 2(2) = 7.0, p = 0.03; therefore, a Greenhouse-
Geisser correction was used and indicated a significant effect of time on nicotine levels, F (1.77, 
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92.2) = 35.7, p < .001. However, no significant condition x time interaction was observed, F 
(1.77, 92.2) = 0.02, p = 0.98. The trend in nicotine levels over time was also quadratic in nature, 
with moderate nicotine dependence at baseline (M = 5.3, SD = .31), low dependence at discharge 
(M = 2.6, SD = 0.36), and low to moderate dependence at the 12-week follow-up visit (M = 3.3, 
SD = 0.33). Pairwise comparisons demonstrated significant differences in nicotine dependence 
across all timepoints (all p < 0.05). Notably, nicotine levels were significantly lower at the time 
of follow-up than levels prior to treatment admission, suggesting many women maintained 
reduced nicotine use following discharge from residential treatment (p < .001).  
The association between nicotine dependence and substance use outcomes was also 
examined across groups using Pearson correlations. While there was no significant relationship 
seen in the study completers sample (p > 0.05), there was a significant positive correlation 
between nicotine dependence and days of any (r = 0.33, p = 0.02) and primary substance use (r = 
0.31, p =0.02) in the intention to treat samples.  
 
Figure 7. Nicotine dependence among baseline smokers at baseline, discharge and 12-week follow-up 
(n=54) 
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Craving. Figure 8 shows the mean craving scores (primary substance) at baseline, 
discharge, and the 12-week follow-up visit for each condition. The Greenhouse-Geisser 
correction was used, as Mauchly’s Test of Sphericity indicated the assumption of sphericity had 
been violated, 2(2) = 8.4, p = .02. As shown in Figure 8, there was a significant effect of time 
on craving, F (1.76, 103.9) = 116.3, p < .001; however, there was not a significant interaction of 
condition x time, F (1.76, 103.9) = 0.7, p = 0.49.  The trend of craving scores over time was 
quadratic in nature, with high craving scores at baseline (M = 10.6, SD = 0.2), low scores at the 
time of discharge (M = 2.8, SD = 0.5), and slightly increased at the 12-week follow-up visit (M = 
4.0, SD = 4.6), and this pattern was consistent across treatment conditions. Pairwise comparisons 
demonstrated significant differences between craving levels across all timepoints (all p < 0.05).  
The association between craving (primary substance) and substance use outcomes was 
also examined across groups using Pearson correlations. There was a significant positive 
correlation between craving and days of substance use in the follow-up period for both days of 
any substance use (r = 0.47, p < 0.001), as well as primary substance use (r = 0.48, p < 0.001). 
This association was seen for women in both the CBT4CBT (r = 0.54, p < 0.01) and TAU 
conditions (r = 0.38, p = 0.04) and was consistent across the intention to treat samples (r = 0.51 – 
0.60, all p < 0.05). 
  
 
65 
 
Figure 8. Craving scores at baseline, discharge and 12-week follow-up (n=61) 
Psychosocial Correlates. Psychosocial correlates of treatment outcomes were also 
explored.  Depression, anxiety, stress, and social support levels across treatment conditions at 
baseline, discharge, and the 12-week follow-up visit are summarized in Table 15. Repeated 
measures ANOVAs indicated no significant treatment condition by time effects for any of the 
psychosocial variables. However, there was a significant effect of time across all surveyed 
variables. For stress, depression, and anxiety, the scores were quadratic in nature, with high 
levels of distress at baseline, low levels at the time of discharge, and slightly increased at the 
time of the 12-week follow-up visit. The scores for social support were also quadratic in nature; 
however, it was in the inverse relationship, with low social support at baseline, high levels at the 
time of discharge, and slightly decreased at the 12-week follow-up visit. This pattern of results 
was consistent across treatment conditions. For depression, social support, and stress, pairwise 
comparisons revealed significant differences between the baseline and discharge assessments, as 
well as the baseline and 12-week follow-up assessment (all p < 0.05). For anxiety, there were 
only significant differences between baseline and discharge levels of anxiety (p < 0.05). 
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Table 15 
 
Psychosocial Correlates of Substance Use Outcomes Across Time (n = 61) 
 
  
CBT4CBT 
n = 33 
 
 
TAU 
n = 28 
 
Group x Time 
Study Variable Estimated Mean Estimated Mean t p 
Depression 
      Baseline 
      Discharge 
      12-week follow-up 
 
26.8 
16.0 
18.1 
 
29.7 
15.1 
20.3 
 
0.93 
 
0.52 
Anxiety 
      Baseline 
      Discharge 
      12-week follow-up 
 
11.1 
9.0 
8.2 
 
11.0 
6.5 
9.3 
 
0.94 
 
0.14 
Stress 
      Baseline 
      Discharge 
      12-week follow-up 
 
23.8 
17.0 
16.3 
 
24.3 
16.5 
18.3 
 
1.0 
 
0.66 
Social Support 
      Baseline 
      Discharge 
      12-week follow-up 
 
25.2 
29.3 
28.6 
 
21.3 
25.3 
24.1 
 
1.0 
 
0.97 
 
Treatment Services Post-Discharge. Treatment services received following discharge 
from residential treatment across conditions are summarized in Table 16. Most participants 
(70.5%) lived with others following discharge from residential treatment. Over one-fifth (21.7%) 
of women in the CBT4CBT condition lived in a structured living situation (recovery house) 
compared to only 4.8% (n = 1) of women in the TAU condition. One participant (4.3%) in the 
CBT4CBT condition was homeless for a portion of the 12-week follow-up period. Regarding 
treatment services received, over three-fourths (77%) of the sample engaged in outpatient 
services following discharge from residential treatment (M = 20.0 days, SD = 15.2 days, range 1-
76) and 9.1% of the sample received inpatient substance use treatment post-discharge (M = 7.5 
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days, SD = 4.5 days). Further, over half (52.3%) of the sample was on medication-based 
treatment for OUD (MOUD) Most of the participants (81.8%) also attended 12-step/self-help 
meetings post-discharge, with 40.9% of the sample reporting use of a sponsor. There were no 
significant group differences in treatment services received during the 12-week-follow-up period 
(all p > 0.05). 
Table 16 
 
Treatment Services Post-Discharge in Treatment Completers (N=44) 
 
 CBT4CBT 
% or M (SD) 
n = 23 
TAU 
% or M (SD) 
n = 21 
 
P value 
Living Arrangement 
       With others 
       Alone 
       Structured living situation (recovery house) 
      Homeless* 
 
65.2% (15) 
13.0% (3) 
21.7% (5) 
4.3% (1) 
 
76.2 (16) 
19.0% (4) 
4.8% (1) 
0% (0) 
 
0.43 
0.59 
0.10 
0.33 
Inpatient Treatment 
       Days of Inpatient Treatment (range 4-14) 
8.7% (2) 
9.5 (6.4) 
9.5% (2) 
5.5 (2.1) 
0.92 
0.49 
Any Outpatient Treatment (% yes) 
      Days of Outpatient Treatment (range 1-48) 
       10 Days of Outpatient Treatment (% yes) 
69.6% (16) 
19.7 (14.5) 
43.5% (10) 
85.7% (18) 
20.3 (16.3) 
61.9% (13) 
0.20 
0.91 
0.22 
Medication-Based Treatment for OUD (% yes) 47.8% (11) 57.1% (12) 0.54 
Engagement in 12-step Program (% yes) 
     12-step/Self-help Meetings (range 1-76) 
     Use of Sponsor (% yes) 
82.6% (19) 
20.2 (20.0) 
52.2% (12) 
81.0% (17) 
22.9 (19.0) 
28.6% (6) 
0.89 
0.68 
0.11 
*Note: The participant who was homeless also lived with others for a portion of the follow-up 
period; she is counted in both of these categories. 
 
 Engagement in Treatment Services and Relapse. Analyses also examined the 
association between outpatient treatment engagement and days of substance use among study 
completers using Pearson correlations. A negative correlation was found between days of 
primary substance use and days of outpatient treatment in the follow up period. This relationship 
was statistically significant for days of primary substance use (r = -0.35, p = 0.02), and 
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approached statistical significance for days of any substance use in the follow-up period (r = -
0.28, p = 0.054). No significant relationship was found between 12-step/self-help meetings and 
days of substance use in the follow-up period for days of any or primary substance use (p > 
0.05). 
Acceptability of the CBT4CBT Program 
 Quantitative Feedback. Lastly, secondary analyses examined the acceptability of the 
CBT4CBT program within residential treatment. Select treatment satisfaction ratings for the 
CBT4CBT program are summarized in Table 17. Participants were asked to rate their level of 
agreement with specific aspects of the CBT4CBT program using a Likert scale with 1 indicating 
low satisfaction and 5 indicating high satisfaction; 22 participants in the CBT4CBT condition 
completed the evaluation prior to leaving residential treatment. Quantitative data revealed high 
satisfaction across all items, with mean ratings ranging from 4.68 (SD = 0.5) to 4.86 (SD = 0.5).  
During this evaluation, participants were also asked if they shared any information about 
the CBT4CBT program with other individuals in residential treatment or allowed anyone else to 
access the modules to assess for any issues of treatment contamination across groups. Four 
women indicated they shared information about the program but noted it was primarily with their 
counselors or other staff in the context of sharing information they had learned in the modules. 
Further, the participant who accessed the program independently while in residential treatment 
indicated she did so via her own tablet and headphones and noted she did not share program 
materials with anyone else in treatment. 
Table 17 
 
Quantitative Feedback on the CBT4CBT Program 
 
 Participants in CBT4CBT Condition (n=22) 
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M (SD) 
General content of computer program 4.77 (0.5) 
Ability to learn from the program 4.73 (0.6) 
Computer program as a tool for learning 4.82 (0.4) 
Computer program was a fun way to learn 4.86 (0.5) 
Applicability of material to your life 4.82 (0.5) 
Homework helped me understand material 4.68 (0.5) 
 
 Qualitative Feedback. Participants were given the opportunity to provide free response 
feedback on aspects of the program they liked, as well as suggestions for improvement. Select 
responses that highlight the primary themes of qualitative feedback are summarized in Table 18. 
Free responses from the women centered largely around the following themes: 1) the content of 
the CBT4CBT program, 2) the mode of treatment delivery, and 3) areas for improvement. 
Regarding content of the CBT4CBT program, participants expressed overall satisfaction 
with the material and that they found the program helped them learn coping strategies for their 
substance use. Participants indicated that the program was easy to understand and the material 
was relatable, with many women noting they liked the use of real-life scenarios to illustrate 
concepts. Finally, participants indicated they liked the True/False questions at the end of each 
module as an opportunity to test their knowledge. In particular, participants indicated the 
questions promoted their self-efficacy by demonstrating that they were engaged and learned the 
content in the module. 
Participants also indicated overall satisfaction with the use of technology to deliver the 
CBT4CBT program. The women noted that while some of the material overlapped with content 
covered in their groups, the video content provided the opportunity to view the application of 
CBT skills in real-life scenarios. Participants also indicated they enjoyed the individualized 
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nature of the program and working through the material independently. Many participants 
described completing the modules as protected time for them to work through material at their 
own pace and without distractions. 
Participants offered a number of specific suggestions as areas of improvement in the 
CBT4CBT program.  Many women noted that the narrator at times talked too much and felt that 
the pace of the program was occasionally slower than they would like. In addition, women 
expressed some frustrations with the program taking time to load or difficulties with the internet 
connection at the treatment program. Consistent with women indicating the videos were one of 
their favorite components of the CBT4CBT program, many noted they would have liked even 
more video examples throughout the program. Participants indicated they would like to have 
more characters from diverse backgrounds and a range of scenarios for skill demonstration. In 
particular, one participant expressed interest in more gender-specific examples and more 
testimonials from women.   
Table 18 
 
Qualitative Feedback on the CBT4CBT Program 
 
Theme: Participant Comments: 
Content of the Program "All the different stuff I didn't know about my triggers and craving, 
[CBT4CBT] helped me understand them a little better. For as long 
as I've been doing drugs I didn't even know that stuff played a part."  
 
“The modules were understandable/relatable and they taught you 
great coping skills to use in certain situations.” 
 
“I liked how it went into detail in different people's lives, and how it 
had the different scenarios, and how to rethink situations, and live 
life differently instead of using.” 
 
"I liked the questions at the end to test the knowledge of what I 
learned…I am so proud of myself. You can see how much I paid 
attention in this module because I got them all right!" 
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Mode of Treatment 
Delivery 
"It was my first time doing something on the computer. I liked seeing 
people in the same situation as me and learning how to cope with 
triggers." 
 
“I thought it was more helpful than group sessions because it 
allowed me to work through things on my own.” 
 
“Some parts overlapped with group, but getting it [the information] 
from the modules made it easier for me to see it in action. In group 
there are no visuals to show what we're learning. Those helped me a 
lot.” 
 
“The videos were very helpful because they are realistic and they 
include everyday scenarios when you are dealing with addiction.” 
 
Areas for Improvement “The narrator talked too much before the modules actually started.” 
 
“Sometimes it took a long time to load.” 
 
“More videos of people that are struggling. More videos with other 
people in addition to Anna and Sam. You could do a new person and 
situation with each topic.” 
 
“Maybe make it gender specific, more women examples and 
testimonials.” 
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Discussion 
The present study provided benchmark data on the use of CBT4CBT in a residential 
treatment program for women with SUDs. The study expanded on current literature supporting 
the use of CBT4CBT in outpatient settings and conducted a 2-arm RCT with N = 63 women in 
residential treatment who were randomized to either TAU with access to the CBT4CBT program 
or TAU alone. The study compared relapse rates following discharge from residential treatment, 
examining both relapse Y/N and number of days of substance use. Analyses were completed 
separately for MOUD and no-MOUD groups. Study outcomes (e.g., days of use) were used to 
estimate effect size to determine the sample size needed for an adequately powered RCT of the 
intervention. The study also examined coping strategy scores over time across groups, as well as 
the association between coping and substance use outcomes. In addition, exploratory analyses 
looked at psychosocial correlates of treatment outcomes and their relationship with substance use 
in the follow-up period. Finally, the study assessed the acceptability and feasibility of 
implementing CBT4CBT program within a residential treatment program. 
Effect of CBT4CBT on Substance Use 
 Primary Outcomes. The present study predicted women in the CBT4CBT group would 
be less likely to relapse and report fewer days of substance use compared to women in TAU 
during the 12-week follow-up period. Rates of relapse post-residential treatment were similar to 
estimates seen in the literature (e.g., 37%-56%; Andersson et al., 2019; Sannibale et al., 2003; 
Brunette et al., 2001; Ouimette et al., 1998); however, women in the CBT4CBT condition 
seemed to have more positive outcomes relative to TAU. Although the present study was not 
powered for statistical significance, findings were in the predicted direction, with women in the 
CBT4CBT group reporting lower likelihood of relapse, longer time to relapse, and fewer days of 
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substance use in the follow-up period compared to TAU. Further, the pattern of results supported 
CBT4CBT, as relapses in the TAU condition were almost exclusively to primary substance, 
while only a subset of relapses in the CBT4CBT condition were to primary drug of abuse. Taken 
together, present findings suggest the intervention may have been having an effect.  
Relapse rates and treatment outcomes in the present study were comparable to previous 
research examining CBT4CBT as an adjunct to outpatient treatment (Carroll et al., 2008; Carroll 
et al., 2009; Carroll et al., 2014). Further, the pattern of results through the 12-week follow-up 
are consistent with research demonstrating durability of effects of the CBT4CBT program. 
Previous literature has shown comparable effects of CBT4CBT in both MOUD and abstinence-
based treatments (Carroll et al., 2009; Carroll et al., 2014); however, there has yet to be any 
direct comparisons between these treatment modalities within the same program. 
Medication-Based Treatment for OUD. While it was not an initial aim of the study, 
given that over half (54%) of the sample received MOUD as part of their treatment, additional 
analyses examined whether CBT4CBT may have had greater impact for the abstinence-based as 
compared to MOUD treatments. Although the groups did not significantly differ, treatment 
outcomes showed particular benefit from the CBT4CBT program among women receiving 
nonpharmacological treatment. This pattern of results is consistent with literature identifying 
MOUD as a predictor of treatment attendance and retention, as well as positive treatment 
outcomes (Svikis et al., 1997; Timko et al., 2016; Jancaitis et al., 2020). Further, present study 
findings are consistent with research suggesting behavioral interventions, such as CBT4CBT, 
may be particularly beneficial among women receiving nonpharmacological treatment who may 
be at higher risk of treatment dropout and relapse (Svikis et al., 1996). While this pattern of 
results could reflect differences by type of substance use problems (e.g., opioids vs. alcohol or 
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cocaine), previous research is mixed, with some studies finding no relationship between type of 
substance use problem and treatment outcomes (e.g., McCaul et al., 2001). Instead, patient 
demographics (gender, race, employment status) were the best predictors of treatment 
participation and retention.  
Effect Size Estimation. Although the original proposed study expected n=70 participants 
with 85% (N=60) follow-up rates, the present study enrolled N=63 participants with 70% (N=44) 
through at least the 4-week follow-up visit due to many factors described in later sections. Thus, 
a primary goal of the present study was to obtain effect size estimates for future RCTs of 
CBT4CBT in residential treatment. Using days of substance use, the present study supported a 
small to medium effect size (range 0.27—0.48) and calculated the sample sizes required for 
future RCTs to detect an effect for both relapse to any (155-217 per group) and primary 
substance (70-110). Notably, analyses of treatment outcomes among women not prescribed 
MOUD yielded moderate to large effect sizes (range 0.55-0.79), further supporting the potential 
benefit of additional studies examining the use of CBT4CBT in patients receiving 
nonpharmacological treatment. Effect sizes in the present study are comparable to those seen in 
studies examining CBT4CBT in outpatient settings (range 0.19-0.59, Carroll et al., 2008; Kiluk 
et al., 2018).  
Coping Strategies. Since a primary aim of the CBT4CBT program is to teach coping 
strategies for substance use, the present study predicted women in the CBT4CBT group would 
have higher coping scores across study visits (e.g., discharge and 12-week follow-up) compared 
to TAU, and higher coping would be associated with a lower risk of relapse in the 12-week 
follow-up period. While no significant group differences in coping scores were found, a 
moderate negative correlation was found between coping scores and days of substance use in the 
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12-week follow-up period. Further, this relationship was stronger among women in the 
CBT4CBT group.  This pattern of results is consistent with previous CBT4CBT research 
(Sugarman et al., 2010) and suggests women used coping strategies at equal rates regardless of 
treatment group, but that women in the CBT4CBT group used them more effectively. Previous 
CBT4CBT research has gone beyond examining the quantity of coping strategies, assessing 
instead the quality of coping responses using behavioral role-play exercises (Kiluk et al., 2010).  
Such research has found improved quality of coping with CBT4CBT compared to TAU and that 
the quality of coping mediated the effect of treatment on substance use (Kiluk et al., 2010). The 
use of such a measure was out of the scope of the present pilot study but offers an exciting area 
for future research to examine this relationship within a residential treatment program.    
Exploratory Analyses 
 Engagement in CBT4CBT Program. Present study findings supported a dose-response 
to the CBT4CBT program in which greater exposure to the material (e.g., number of modules 
completed) was negatively correlated with days of substance use in the follow-up period. The 
nature and strength of this relationship is consistent with that seen in studies examining 
CBT4CBT in outpatient settings (Carroll et al., 2009). The importance of patients receiving an 
adequate ‘dose’ of psychotherapy that results in clinically meaningful changes is well-
documented in clinical research (Hansen et al., 2002). Such relationships have been found in the 
CBT literature (Dutra et al., 2008), as well as other behavioral interventions in the field of 
addiction (e.g., Ngjelina, 2019; Hien et al., 2012; McHugh et al., 2010; Tross et al., 2008). 
Smoking and Nicotine Dependence. Baseline rates of smoking in the present study 
(88.9%) were consistent with national estimates (77.9%) of smoking in SUD treatment samples 
(Guydish et al., 2016). While national prevalence rates of smoking have steadily decreased over 
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the past decade, with approximately 13.7% of U.S. adults reporting smoking in 2018 (CDC, 
2018), rates of smoking among individuals seeking SUD treatment remain high (Gubner et al., 
2019). In an effort to address this disparity, approximately one-third of SUD treatment programs 
in the U.S. have implemented tobacco-free policies and increased availability of smoking 
cessation services, including nicotine-replacement therapy (NRT) and behavioral interventions 
(Gubner et al., 2019). With RBHA-NC being a smoke-free treatment facility, study participants 
were unable to smoke while on-site and were offered NRT and behavioral counseling as part of 
their treatment.  
Despite such policies, the majority (87.5%) of women who smoked at baseline had 
resumed smoking by the 12-week follow-up visit regardless of RCT group assignment. These 
results are consistent with research showing low rates of continued smoking abstinence 
following discharge from smoke-free residential treatment facilities (Brose et al., 2018; Gariti et 
al., 2002; Ingram et al., 2017). While few participants maintained full abstinence following 
discharge, levels of nicotine dependence (FTND) among baseline smokers (M = 5.3, SD = .31) 
had significantly decreased by the 12-week follow-up visit (M = 3.3, SD = 0.33), suggesting 
maintained reductions in nicotine use following residential treatment. This is consistent with 
previous research suggesting that smoke-free policies in residential treatment may promote 
maintained reductions in cigarette use following discharge (Gariti et al., 2002; Joseph et al., 
1990).  
Many participants in the present study noted reinitiating smoking during residential 
treatment when they transitioned to a lower intensity of residential services (3.1 level of care) 
and had day passes for activities outside of the treatment facility. It may be that this pattern of 
use resulted in reduced cigarette use that was then maintained post-discharge from residential 
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treatment. However, the present study was limited by the FTND as its only measure of smoking 
behavior and incomplete data on the use of NRT in the follow-up period. Varied measures of 
smoking (e.g., cigarettes smoked, biological measures) and use of NRT products would be 
important to explore in future research to gain a better understanding of smoking behavior and 
quit attempts, as research has shown variability across assessment methods (e.g., Blank et al., 
2016). 
Previous research has demonstrated an increased risk of substance use relapse among 
smokers with SUDs who continue to smoke (Weinberger et al., 2017). While the present study 
found a significant positive correlation between FTND scores and days of substance use in the 
intent-to-treat analyses., this finding should be interpreted with caution due to the presumed 
relapses in the intent-to-treat samples and carrying forward of missing FTND data. The present 
study was limited in its ability to account for underlying reasons for this observed relationship; 
however, several factors have been explored in previous research. Smoking often cooccurs with 
other substance use, and cigarettes may become a cue for use of other drugs, increasing the risk 
for relapse (Weinberger et al., 2017). Further, combined use of nicotine and other drugs has been 
linked with greater psychiatric and personality disorders, which is associated with greater 
difficulty quitting (Ziedonis et al., 2008) and higher rates of SUD treatment dropout (Brorson et 
al., 2013).  
 Craving. The present study found no group differences in craving levels over time; 
however, interesting patterns in craving for the entire sample were observed. Consistent with 
previous research showing a positive effect of treatment on reducing craving (Serre et al., 2015; 
Oslin et al., 2009), the present study found craving significantly decreased over the course of 
residential treatment. At 12 weeks post-discharge, however, craving had significantly increased, 
  
 
78 
with a positive correlation between levels of craving (primary drug) and days of substance use. 
Research has long debated the role of craving in the relapse process (Wray et al., 2013), 
emphasizing the importance of examining this relationship in the context of other factors in the 
addictive process (e.g., environment, cues; Sayette, 2016). Particularly within the context of 
residential treatment, this pattern of results likely reflects participants being exposed to cues for 
use following their discharge from residential care, resulting in an increase in drug cravings and 
risk for relapse. Even in the context of day passes prior to discharge, these passes were typically 
to go to work or to pursue other services (e.g., housing, employment), still providing structured 
activity, as well as the known expectation that UDS/breathalyzer would be obtained upon return 
to the residential facility. Thus, the post-discharge period represents a time of reduced control 
and overall structure, as well as a concurrent increase in cues for substance use. 
 Psychosocial Correlates of Treatment Outcomes. No group differences were observed 
across psychosocial correlates of treatment outcomes, including depression, anxiety, stress, and 
social support. The pattern of results across all psychosocial variables were quadratic in nature, 
with high levels of distress at baseline, reduced levels at discharge, and slight increases in at the 
12-week follow-up visit. Notably, distress levels at the 12-week follow-up did not return to those 
seen at baseline. Present study findings are consistent with previous research demonstrating 
significant reductions in psychosocial distress over the course of residential treatment (Ross et 
al., 2019). Further, the increase in distress post-discharge is likely a reflection of leaving the 
controlled setting offered by residential treatment and being confronted with environmental 
stressors. This level of distress is likely more representative of typical psychosocial functioning, 
as entry to residential treatment is often a time of heightened distress and such symptoms 
typically dissipate during the course of SUD treatment (e.g., Svikis et al., 1996). Previous 
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research has demonstrated the importance of exploring these factors in substance use treatment, 
with studies linking depression and anxiety to an increased risk for relapse following residential 
treatment (Bobo et al., 1998; Gil-Rivas et al., 2009; Suter et al., 2011; Moitra et al., 2013). 
Further, research has demonstrated a link between social support, the quality of social 
relationships, and risk for relapse post-discharge (Ellis et al., 2004).     
 Treatment Services Post-Discharge. No group differences were found in the level of 
engagement in outpatient services post-discharge, with both groups demonstrating high rates of 
continuity of care. Over three-fourths (77%) of the sample reported at least one day of outpatient 
substance use care in the follow-up period, which is higher than those seen in previous research 
examining continuity of care following discharge from residential treatment (rates ranging from 
15%-60%; Costello et al., 2019; Bergman et al., 2015; Garnick et al., 2009; Schaefer et al., 
2005). Further, many participants appeared to be engaging in regular outpatient visits (e.g., 
weekly), with over half (52.3%) of the sample reporting  10 days of outpatient treatment in the 
follow-up period. The present findings are consistent with research supporting the value of 
continuity of care, with a negative correlation found between days of primary substance use and 
days of outpatient treatment in the follow-up period (r = -0.35, p = 0.02). Continuity of care 
following residential treatment has been linked with improved substance use outcomes (Blodgett 
et al., 2014; DeMarce et al., 2008), as well as lower risk of death two years following discharge 
(Harris et al., 2015).  
 The high rates of treatment engagement post-discharge from residential care is likely a 
reflection of the treatment network provided by RBHA in Richmond, Virginia and program 
efforts to facilitate connection to outpatient services prior to discharge. Further, rates of MOUD 
in the present sample also likely contributed to this pattern of results, as all women on MOUD 
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engaged in outpatient services post-discharge from residential care, and rates of women reporting 
 10 days of treatment were higher among women receiving MOUD (65.2%) as compared to the 
no-MOUD group (34.8%). Taken together, the high rates of continued care may have served to 
buffer treatment effects of the CBT4CBT intervention that may be seen in other residential 
treatment facilities with fewer opportunities for and engagement in continued care following 
discharge.  
 Consistent with outpatient treatment, the present study also showed high rates (81.8%) of 
engagement in 12-step/self-help meetings post-discharge; engagement rates were consistent with 
those seen in recent research (83.6%; Costello et al., 2019). While previous research has 
demonstrated associations between engagement in 12-step/self-help activities and positive 
treatment outcomes (Donovan et al., 2013; Costello et al., 2019), the present study did not find 
such a relationship. Despite present study findings, the value of such programs cannot be 
underestimated, offering a free, easily accessible, flexible, and supportive network to individuals 
in recovery. Previous research has found engagement in 12-step meetings is associated with 
reduced substance use, psychosocial improvements, and promotion of continued recovery 
(Costello et al., 2019).  
Acceptability and Feasibility of CBT4CBT in Residential Treatment 
 Another primary aim of the present study was to examine the acceptability and feasibility 
of implementing the CBT4CBT program within a women’s residential treatment facility. 
Quantitative satisfaction ratings with the CBT4CBT program were high and consistent with 
those seen in outpatient settings (Carroll et al., 2008; Kiluk et al., 2016). Similarly, qualitative 
feedback revealed largely positive perceptions of the CBT4CBT program consistent with many 
of the hypothesized benefits of technology-based interventions, such as providing varied 
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examples, the ability to tailor content to patient needs, and learning the material via media rich 
content (Moore et al., 2011; Marsch, Carroll & Kiluk, 2014). Interestingly, some of the women 
noted that while some of the CBT4CBT material overlapped with content covered in group, they 
also enjoyed learning it via modules because it enabled them to work through the content without 
outside distractions and the opportunity to see the skills applied in real-life scenarios. These 
comments highlight the potential benefits of CBT4CBT specifically within residential treatment. 
First, the CBT4CBT modules may offer the opportunity to see relapse prevention and other skills 
applied outside the controlled environment offered by the residential facility. Second, residential 
treatment includes many groups and structured activities, and the CBT4CBT program may 
provide a varied treatment modality to provide patients with the option of practicing skill 
development independently and tailoring content to their needs. 
Regarding feasibility of implementing the CBT4CBT program in a residential treatment 
setting, the CBT4CBT modules were able to be completed during breaks from residential 
treatment activities with minimal disruption to clinical care. Women often completed modules 
during snack breaks or downtime between groups. Research staff were on-site to help navigate 
the program, but women largely completed the modules independently. Further, rates of 
treatment engagement were consistent with those seen in outpatient settings, with women 
completing a mean of 5 modules (SD = 2) and over two-thirds (72.4%) completing six or more 
modules. Taken together, the present study supported the feasibility and acceptability of 
CBT4CBT in residential treatment.  
Participants also identified areas for improvement of the CBT4CBT program with many 
advocating for an increase in the number of vignettes to choose from when illustrating different 
CBT concepts. This feedback speaks to participants valuing this aspect of the CBT4CBT 
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program and the importance of including examples that can be flexibly applied to diverse 
situations and patient populations. Recent CBT4CBT research has focused on developing such 
content, with a recent study of CBT4CBT-Spanish, a culturally adapted version of the 
intervention (Paris et al., 2018). CBT4CBT-Spanish uses a telenovela format to promote patient 
engagement and provide culturally relevant examples to learn CBT concepts. Treatment 
outcomes showed significantly greater reductions in days of primary substance use in those 
assigned to CBT4CBT-Spanish compared to those who received standard treatment alone.  
In addition to general feedback for more case vignettes, one participant in the present 
study suggested a need for more gender-specific examples and content tailored to women. This 
has empirical support, as gender-specific treatments have demonstrated higher retention rates, 
less substance use, and fewer barriers to care (Polak et al. 2015; Grella, 2008; Campbell et al., 
2005; Hser et al., 2011; Ashley et al., 2003). This feedback suggests that such approaches in the 
development of technology-based interventions may also be warranted. Specifically, gender-
specific content in interventions focused on relapse prevention may be beneficial, as research has 
demonstrated gender differences in reasons for relapse (Tuchman, 2010; Rubin Stout, & 
Longabaugh, 1996; McKay et al., 1996).  
Study Implications and Applications 
This study has a number of important implications. First, it provides benchmark data on 
the use of CBT4CBT in residential treatment and demonstrates acceptability and feasibility of 
the program comparable to that seen in outpatient settings (Carroll et al., 2008; 2014; Kiluk et 
al., 2018). The CBT4CBT program offers the potential to disseminate CBT more broadly, across 
a range of patient populations and treatment settings where it is not currently accessible to 
patients. The program offers a feasible, cost-effective intervention to reduce barriers to evidence-
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based care for individuals with SUDs, as well as offering an intervention with standardized 
treatment delivery, media-rich content, and the ability to tailor content to patient needs. 
 This study is also the first study to examine the CBT4CBT program specifically in a 
sample of drug-dependent women. Research has shown women have unique risk factors for 
substance use (Greenfield et al., 2007; Greenfield et al., 2010), and additional barriers to 
accessing care (e.g., housing, childcare; Terplan, Longinaker, & Appel, 2015; Polak et al., 2015; 
Greenfield et al., 2007; Green, 2006; Ashley, Marsden, & Brady, 2003). CBT4CBT may prove 
particularly useful in providing access to evidence-based treatment in this population. Further, 
research has shown gender difference in reasons for relapse (Tuchman, 2010; McKay et al., 
1996; Messer et al., 2018) and that women may particularly benefit from CBT (Magill & Ray, 
2009), suggesting the CBT4CBT program may represent a particularly promising intervention 
for women with SUDs. Additional research examining CBT4CBT in women, as well as studies 
of gender differences in treatment outcomes is warranted.   
Study Strengths, Limitations, and Future Directions 
Strengths. The present study had a number of strengths.  First, inclusion criteria were 
broad, promoting heterogeneity and sample representativeness of women in residential treatment 
for SUD. Also, women with comorbidities, polysubstance use, and varying ethnic backgrounds 
were all eligible for study participation, allowing the data to reflect the complexities often seen in 
residential SUD programs. 
 Second, the use of a technology-based intervention offered high levels of control and 
standardization over intervention delivery, ensuring fidelity across study participants. Further, 
the CBT4CBT program offers opportunities to track clinical contact (e.g., access to the program, 
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time taken in each module), allowing investigators to assess dose of the intervention that was 
received. Such data is often unavailable in studies of behavioral and psychosocial interventions.  
 Third, phone-based assessments were included at weeks 1, 2, and 3 post-discharge from 
residential treatment as a means of maintaining contact with study participants and increasing 
follow-up rates at 4 and 12-weeks post-discharge from residential care, supporting the utility of 
such procedures. Present study findings demonstrated success with this approach, with 
completion rates of the phone-based assessments increasing each week post-discharge.  
 Fourth, the study included biological measures of substance use (e.g., urine drug screen, 
breathalyzer), offering confirmatory measures of self-report data. Further, the study emphasized 
that the research study was independent of the women’s treatment, that all data was anonymous, 
and would not be shared with RBHA-NC staff. Such procedures promoted participant 
confidentiality and overall comfort with study participation. 
 Lastly, the study used a conservative approach to handle missing data by assuming all 
missing substance use data in the follow-up period as ‘presumed relapsed’ on day one post-
discharge from residential treatment. This approach is commonly used in substance use research 
to provide a conservative estimate of treatment effects.  Further, the study included intent-to-treat 
analyses of outcomes to include all randomized participants in study analyses.   
Limitations. Despite these strengths, the study also had a number of limitations. First, 
the study was limited by a small sample size. This was due in part to delays in study startup due 
to renovations at the RBHA-NC facility, which were scheduled to be completed in March 2018 
but were not finished until summer of 2018. During this time, patient census at the program was 
lower than projected and there was considerable staff (and client) stress during the transition and 
subsequent opening of a new floor in the residential facility. 
  
 
85 
 Second, follow up rates (60.3%) were lower than anticipated based on those achieved in 
earlier research at the target facility (e.g., 75% by Langhorst et al., 2012) and more broadly in the 
community (e.g., 80% by Svikis et al., 2012). The lower rate of follow-up in the present study 
was due in part to funding limitations, resulting in reduced staffing that was central to our ability 
to successfully track and assess study participants who were at high risk for relapse.  
 Another limitation was the reliance primarily on self-report measures of substance use. 
While biological measures were available when 4 and 12-week follow up assessments were 
completed in-person, many women were unable to complete face-to-face visits due to moving 
from the area or having limited transportation, which necessitated that the follow up visit be 
completed over the phone. Funding limitations and minimal staffing also contributed to an 
increase in phone-based follow-ups toward the end of the study.  
Finally, the present study was limited to scheduling CBT4CBT sessions at times that did 
not conflict with residential treatment activities. This was due in part to practical issues of 
implementing CBT4CBT as an adjunct to intensive residential treatment and limited participant 
availability. Further, limited staffing and RA/PI availability on-site likely impeded participant 
access to the program. However, despite this limitation, the present study achieved engagement 
rates consistent with those seen in outpatient settings, suggesting present data may be an 
underestimate of what CBT4CBT engagement may look like in residential treatment with 
unrestricted access to the program. 
Future Directions. The present study expanded on the current research supporting the 
use of CBT4CBT in outpatient care and serves as the first RCT of CBT4CBT for women in 
residential treatment for substance use disorders. Present study outcomes can inform sample size 
estimates for a larger RCT of CBT4CBT in residential treatment. Further, such research could 
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begin to include less tightly controlled effectiveness trials to examine clinical outcomes when 
delivered in clinical practice. 
Second, women in the CBT4CBT arm of the RCT were offered the online sessions in 
addition to TAU. While TAU was substantive, there was nonetheless a difference in time and 
attention for the CBT4CBT group. Future research should compare CBT4CBT to an attention 
control group or an alternative intervention (e.g., guided imagery or mindfulness). This is 
important as contact alone may have a measurable effect on the outcome variables of interest. 
 Finally, future research should build on present study findings and continue to evaluate 
potential gender differences in CBT4CBT with attention given to potential tailoring of content. 
For example, given demonstrated gender differences in reasons for relapse (Tuchman, 2010; 
Rubin Stout, & Longabaugh, 1996; McKay et al., 1996), certain content and examples may be 
particularly salient to specific patient populations. More research is needed focused on tailoring 
to meet the needs of patient subgroups (e.g., CBT4CB-Spanish; Paris et al., 2018) and type(s) of 
substance use problems (e.g., alcohol dependence, Choi et al., 2011), as well as MOUD versus 
abstinence-based treatment, smoking cessation and relapse prevention. Such efforts should 
explore ways of tailoring content specifically to patients in residential treatment programs, such 
as exercises or videos related to their experiences (e.g., smoke-free treatment facilities) and 
relapse prevention post-discharge. 
Conclusion 
The present study provided benchmark data on the use of CBT4CBT in a residential 
treatment program for women with SUDs. Although the present study was not powered for 
statistical significance, findings were in the predicted direction, with women in the CBT4CBT 
condition reporting fewer relapses, longer time to relapse, and fewer days of substance use in the 
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follow-up period compared to TAU. Further, treatment effects were stronger in women receiving 
nonpharmacological treatment, suggesting behavioral interventions may be particularly 
beneficial in this patient population. The present study extends the current body of literature 
supporting CBT4CBT in outpatient settings and provides pilot data to inform the design of a 
larger RCT in residential treatment. This body of research has important implications for SUD 
treatment, offering the potential to expand the reach of evidence-based addiction treatment 
across diverse treatment settings and patient populations. 
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Appendix A 
General Information 
 
1) How old are you? __________ yrs. 
 
2) Of what race do you consider yourself? 
_____ Black/African American   _____ Native Hawaiian or Other Pacific Islander 
_____ White/Caucasian    _____ Asian 
_____ American Indian or Alaskan Native  _____ Other (Specify: ____________________) 
 
3) What is your marital status? 
____ Single/Never Married     ____ Widowed 
____ Married/Living as Married (5+ yrs together)  ____Other  
____ Divorced/Separated 
 
4) How much education have you completed? 
____ Grades 1 through 8     ____ Associates degree 
____ Grades 9 through 11     ____ Bachelor’s degree 
____ Grade 12 or GED    ____ Technical training 
____ Some college 
 
5) What was your usual employment pattern (before entering RBHA)? 
____ Employed Full Time (40 hrs/week)   ____ Homemaker/Mom 
____ Employed Part Time     ____ Unemployed 
____ Student       ____ Disabled 
 
6) How many children do you have? _________ kids 
    How many currently live with you? _________ kids 
 
7) Describe your current living situation (past year) 
____ With partner/spouse alone   ____ Alone 
____ With partner/spouse and kids   ____ With family/friends 
____ With kids alone (single parent)   ____ Other 
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Brief Substance Craving Scale 
 
Please answer the following questions with regard to your primary drug of abuse. 
1. The INTENSITY of my craving, that is, how much I desired this drug in the past 24 
hours: 
0 None at all  
1 Slight  
2 Moderate  
3 Considerable  
4 Extreme 
 
2. The FREQUENCY of my craving, that is, how often I desired this drug in the past 24 
hours: 
0 Never  
1 Almost never      
2 Several times  
3 Regularly  
4 Almost constantly 
 
3. The LENGTH of time I spent in craving this drug during the past 24 hours was: 
0 None at all  
1 Very Short       
2 Short 
3 Somewhat long  
4 Very long 
 
4. Write the NUMBER of times you think you had craving for this drug during the past 24 
hours: ____________ 
 
5. Write in the total TIME spent craving this drug during the past 24 hours:___________ 
 
6. WORST day: During the past week my most intense craving occurred on the following 
day: 
Options: Sunday-Saturday; All days of the same (skip to Q#8) 
 
7. The date for that day was:_____________ 
 
8. The INTENSITY of my craving, that is, how much I desired cocaine on that worst day 
was: 
0 None at all  
1 Slight  
2 Moderate  
3 Considerable  
4 Extreme 
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Fagerstrom Test for Nicotine Dependence 
 
1. How soon after you wake up do you smoke your first cigarette? 
• Within 5 minutes 
• 6 to 30 minutes 
• 31 to 60 minutes 
• After 60 minutes 
2. Do you find it difficult to refrain from smoking in places where it is forbidden (e.g., in 
church, at the library, in the cinema)? 
• Yes 
• No 
3. Which cigarette would you hate most to give up? 
• The first one in the morning 
• Any other 
4. How many cigarettes per day do you smoke? 
• 10 or less 
• 11 to 20 
• 21 to 30 
• 31 or more 
5. Do you smoke more frequently during the first hours after waking than during the rest of 
the day? 
• Yes 
• No 
6. Do you smoke when you are so ill that you are in bed most of the day? 
• Yes  
• No 
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Center for Epidemiological Studies Depression Scale (CES-D) 
 
During the past week Rarely or none of 
the time (less 
than 1 day) 
Some or a little 
of the time (1-2 
days) 
Occasionally or 
a moderate 
amount of time 
(3-4 days) 
Most or all 
of the time 
(5-7 days) 
1. I was bothered by 
things that usually 
don’t bother me. 
    
 
2. I did not feel like 
eating; my appetite 
was poor. 
    
3. I felt that I could not 
shake off the 
blues even with help from 
my family or 
friends. 
    
4. I felt I was just as good 
as other 
people. 
    
5. I had trouble keeping 
my mind on 
what I was doing. 
    
6. I felt depressed.     
7. I felt that everything I 
did was an effort. 
    
8. I felt hopeful about the 
future. 
    
9. I thought my life had 
been a failure. 
    
10. I felt fearful.     
11. My sleep was restless.     
12. I was happy.     
13. I talked less than 
usual. 
    
14. I felt lonely.     
15. People were 
unfriendly. 
    
16. I enjoyed life.     
17. I had crying spells.     
18. I felt sad.     
19. I felt that people 
dislike me. 
    
20. I could not get 
“going.” 
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Generalized Anxiety Disorder 7-item 
 
Over the last 2 weeks, how 
often have you been 
bothered by the following 
problems? 
Not at all Several Days More than half 
the days 
Nearly every 
day 
1. Feeling nervous, 
anxious, or on edge 
0 1 2 3 
2. Not being able to stop 
or control worrying 
0 1 2 3 
3. Worrying too much 
about different things 
0 1 2 3 
4. Trouble relaxing 0 1 2 3 
5. Being so restless that it 
is hard to sit still 
0 1 2 3 
6. Becoming easily 
annoyed or irritated 
0 1 2 3 
7. Feeling afraid as if 
something awful might 
happen 
0 1 2 3 
 
 
Add columns 
Total Score 
   
8. If you checked off any 
problems, how 
difficulty have these 
problems made it for 
you to do your work, 
take care of things at 
home, or get along with 
other people? 
 
 
Not difficult at 
all 
 
 
Somewhat 
difficult 
 
 
Very Difficult 
 
 
Extremely 
difficult 
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Perceived Stress Scale 
 
The questions in this scale ask you about your feelings and thoughts during the last month. In 
each case, you will be asked to indicate by circling how often you felt or thought a certain way.  
 
0 = Never 1 = Almost Never 2 = Sometimes 3 = Fairly Often 4 = Very Often 
 
1. In the last month, how often have you been upset because  
of something that happened unexpectedly?     0    1    2    3    4  
 
2. In the last month, how often have you felt that you were  
unable to control the important things in your life?    0    1    2    3    4 
 
3. In the last month, how often have you felt nervous  
and “stressed”?        0    1    2    3    4 
 
4. In the last month, how often have you felt confident  
about your ability to handle your personal problems?   0    1    2    3    4 
 
5. In the last month, how often have you felt that things  
were going your way?       0    1    2    3    4 
 
6. In the last month, how often have you found that you  
could not cope with all the things that you had to do?   0    1    2    3    4 
 
7. In the last month, how often have you been able to  
control irritations in your life?      0    1    2    3    4 
 
8. In the last month, how often have you felt that you  
were on top of things?       0    1    2    3    4 
 
9. In the last month, how often have you been angered  
because of things that were outside of your control?   0    1    2    3    4 
 
10. In the last month, how often have you felt difficulties  
were piling up so high that you could not overcome them?   0    1    2    3    4 
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Interpersonal Support and Evaluation List-12 
 
This scale is made up of a list of statements each of which may or may not be true about you. For 
each statement check “definitely true” if you are sure it is true about you and “probably true” if 
you think it is true but are not absolutely certain. Similarly, you should check “definitely false” if 
you are sure the statement is false and “probably false” is you think it is false but are not 
absolutely certain. 
 
1. If I wanted to go on a trip for a day (e.g., to the mountains, beach, or country), I would 
have a hard time finding someone to go with me.  
____definitely true ____probably true ____probably false ____definitely false 
 
2. I feel that there is no one I can share my most private worries and fears with. 
____definitely true ____probably true ____probably false ____definitely false 
 
3. If I were sick, I could easily find someone to help me with my daily chores. 
____definitely true ____probably true ____probably false ____definitely false 
 
4. There is someone I can turn to for advice about handling problems with my family.  
____definitely true ____probably true ____probably false ____definitely false 
 
5. If I decide one afternoon that I would like to go to a movie that evening, I could easily 
find someone to go with me. 
____definitely true ____probably true ____probably false ____definitely false 
 
6. When I need suggestions on how to deal with a personal problem, I know someone I can 
turn to.  
____definitely true ____probably true ____probably false ____definitely false 
 
7. I don’t often get invited to do things with others. 
____definitely true ____probably true ____probably false ____definitely false 
 
8. If I had to go out of town for a few weeks, it would be difficult to find someone who 
would look after my house or apartment (the plants, pets, garden, etc.). 
____definitely true ____probably true ____probably false ____definitely false 
 
9.  If I wanted to have lunch with someone, I could easily find someone to join me. 
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____definitely true ____probably true ____probably false ____definitely false 
 
10. If I was stranded 10 miles from home, there is someone I could call who would come and 
get me. 
____definitely true ____probably true ____probably false ____definitely false 
 
11. If a family crisis arose, it would be difficult to find someone who could give me good 
advice about how to handle it. 
____definitely true ____probably true ____probably false ____definitely false 
 
12. If I needed some help in moving to a new house or apartment, I would have a hard time 
finding someone to help me. 
____definitely true ____probably true ____probably false ____definitely false 
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Participant Tracking Form 
 
Please provide the names, addresses, and phone numbers of three (3) people who are 
likely to know where you will be following treatment. This information will be used only to 
contact you to schedule the post-discharge follow-up visit. You will only say that you are 
participating in a research study. No information about your drug abuse treatment will be 
disclosed without written informed consent from you. 
 
1) Name: _________________________________________ 
 
Address: ____________________________________________ 
 
   ____________________________________________ 
 
Phone Number: __________________________________ 
 
2) Name: _________________________________________ 
 
Address: ____________________________________________ 
 
   ____________________________________________ 
 
Phone Number: __________________________________ 
 
3) Name: _________________________________________ 
 
Address: ____________________________________________ 
 
   ____________________________________________ 
 
Phone Number: __________________________________ 
 
 
 
 
 
 
 
 
 
 
 
 
 
